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The branched-chain amino acids leucine, isoleucine and valine 
are transaminated to their respective a-keto acid analogues; a-keto- 
isocaproate (KIC) a-keto-p-methyIvalerate (KMV) and a-ketoiso- 
valerate (KIV) in normal mammalian tissues. Recently an interest 
in the genetic anomaly "branched-chain ketoaciduria" or "maple 
syrup urine disease", a metabolic disease involving the oxidative 
decarboxylation of the three branched-chain CC-keto acids, has 
stimulated efforts to characterize the nature of the enzymic 
conversions leading from the a-keto acids to their acyl coenzyme A 
products. These studies have been extended toward a consideration 
of the metabolic interrelationships among these a-keto acids (KIC, 
KMV, KIV). Furthermore, the effects of the branched-chain a-keto 
acids upon the metabolism of pyruvate and of a-ketoglutarate have 
been investigated. In addition, there has been an attempt to 
determine whether, in the normal and the abnormal (branched-chain 
ketoaciduric) animal, such interrelationships might constitute a 
significant physiological regulatory mechanism.
a-Keto acid dehydrogenase activities were estimated by the
Ikquantitative measurement of CO^ evolved from carboxyl-labeled a- 
keto acid substrates. The a-keto acid dehydrogenase enzyme 
activities were measured in several fractions of bovine liver 
homogenates prepared by differential centrifugation techniques.
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Subcellular distribution studies established that the branched-
:hain a-keto acid dehydrogenase activities were localized principally 
„n the mitochondri ., and more specifically on the outside of the 
inner membrane of the mitochondria. In addition to the particulate 
activity, minor amounts of dehydrogenase activity with KMV and KIC 
/ere noted in the "soluble" (not sedimented at 80,000 x £ for one 
lour) fraction.
The particulate branched-chain a-keto acid dehydrogenase 
activities were shown to depend upon added nicotinamide adenine 
linucleotide (NAD+) and coenzyme A for maximal activity. Also 
jbserved were apparent requirements fox calcium, magnesium and 
Inorganic phosphate. These findings lend support to the assumption 
:hat the branched-chain a-keto acids are catabolized by a mechanism 
analogous to that known to exist for the well-characterized 
ayruvate and a-ketoglutarate dehydrogenase complexes.
The apparent Michaelis constant for each of these keto acids 
KIC, KMV, KIV, pyruvate, a-ketoglutarate) was determined. In
general, the values for the branched-chain a-keto acids are of the
. -h>rder of 4 x 10 M, while those for pyruvate and a-ketoglutarate
-ij. -I4.ire slightly lower, 0.8 x 10 M and 2 x 10 M respectively.
The degree and type of influence exerted among the various a-
:eto acids was examined directly by following the enzymatic
lip.iberation of CO^ from carboxyl-labeled substrate in the presence 
if an alternate unlabeled a-keto acid. A mutually inhibitory 
iattern among KIC, KIV and KMV was noted. In addition, each of the 
•ranched-chain keto acids exerted a marked inhibition of pyruvate
xiii
dehydrogenase and a-ketoglutarate dehydrogenase activities. 
Inhibitions were of the competitive type in all instances except 
for a-ketoglutarate dehydrogenase activity, where a "mixed" type 
of inhibition was seen. The apparent inhibitor constants were in 
a range such that a significant mutual influence among the branched- 
chain a-keto acids could exist in vi ̂ o . Also, the inhibitory 
effects of KIC upon pyruvate dehydro '.anase could be considered to 
be significant at normal cellular concentrations of these metabolite 
The net effect of the inhibitory action of the branched-chain a-keto 
acids on each other and upon pyruvate dehydrogenase in the normal 
animal is likely a homestatic balance, which allows for catabolism 
of excess branched-chain amino acids, while concurrently 
influencing the flow of pyruvate to acetyl coenzyme A.
The abnormal situation, as obtained in branched-chain keto 
aciduria, results in extremely elevated levels of all three branched 
chain a-keto acids. As these acids accumulate proximal to the 
metabolic block at the level of oxidative decarboxylation, they may 
nearly completely restrict the activity of pyruvate dehydrogenase, 
and exert substantial inhibitory effects at a-ketoglutarate 
dehydrogenase. These effects could severely limit the production 
of energy via the Krebs tricarboxylic acid cycle. In addition, 
production of acyl coenzyme A intermediates necessary for fatty 
acid synthesis would be affected.
Thus, as the result of a genetic.lesion, which is manifest in 
the inability of the animal to catabolize the branched-chain a-keto 
acids, these intermediates accumulate, and in turn may exert a
deleterius influence upon cellular energy requirements, as well 
as on production of essential metabolic intermediates. These 
effects in the abnormal situation could account for many of the 
symptoms observed in branched-chain ketoaciduria.
xv
INTRODUCTION
The branched-chain amino acids leucine, isoleucine and valine,
which are synthesized in bacteria and plants, are essential nutrients
for animals. Coon et al. (l) have studied the general pathways
for the degradation of these three amino acids in mammalian tissues,
and have found that the initial steps follow a similar pattern of
transamination to the respective a-keto acids (a-ketoisocaproate 
1( K i c )  , a-keto-p-methylvalerate (KMV), and a-ketoisovalerate (KIV), 
followed by irreversible oxidative decarboxylation of these branched- 
chain a~keto acids to the corresponding acyl-CoA derivatives, 
as noted in the following simplified reaction scheme:
1) R-CH-COOH — - ------ ------R-C-COOH
i H
HH2 0
2) R-C-COOH + NAD'1' + CoASH -v-- — >  R-C-SCoA + NADH + H+
II ^  II
0 C02 °
The following abbreviations are used in this presentation: KIC, 
a-ketoisocaproate; KIV, a-ketoisovalerate; KMV, a-keto-p-methyl- 
valerate: KB, a-ketobutyrate; KG, a-icetoglutarate; Pyr, pyruvate;
KV, a-ketovalerate; KC, a-ketocaproate; NAD+, nicotinamide adenine 
dinucleotide (oxidized form); NADH nicotinamide adenine dinucleo­
tide (reduced form); CoASH, reduced coenzyme A; EDTA, ethylene- 
diamine Lctm^ei-ic acid; NADP+, nicotinamide adenine dinucleotide 
phosphate; a-GP, DL-a-glycerophosphate; TPP, thiamine pyrophosphate; 
FAD, flavin adenine dinucleotide, FMN, flavin mononucleotide; F^, 
orthophosphate; g, gram; mg, milligram; £, gravity; ml, milliliter; 
cm, centimeter; KA, absorbance change, nm, nanometers, M, molar; 
rr.M, millimolar; min, minute; sec, second; l^COp, carbon-l^-labeled 




The further catabolism of the acyl-CoA compounds apparently 
proceeds via a sequence of reactions similar to those of fatty acid 
0-oxidation. Sparse information is available on the enzymes which 
are involved in these catabolic pathways. However, from the studies 
of Bloch (2) and Coon (3) it is evident that certain of the later 
reactions in the pathways of branched-chain amino acid degradation 
differ considerably from the accepted 0-oxidation scheme. With 
respect to end-products formed from the catabolic processes involved, 
it is generally understood that leucine is ketogenic, valine is 
glycogenic and isoleucine is either ketogenic or weakly glycogenic 
under varying conditions (I+-7). It has been postulated that the 
overall oxidative decarboxylation of KIC, KMV, and KIV proceeds 
by a metabolic conversion analogous to that proposed for pyruvate 
and a-ketoglutarate. Gunsalus (8) and Reed (9) have presented the 
following mechanistic scheme to account for the reaction sequence 
of the oxidation of pyruvate and a-ketoglutarate by their 
respective enzyme complexes;
OH lTPP-enz ---------- ■> R-C-TPP-enz + C0„a a ^
lip-enz,


























FADH -enz + NAD 2 c
+ FADH -enz 2 c
FAD-enz + NADH c H
0
II +Sum: R-C-COO + CoASH + NAD
0
II +R-C-SCoA + CO + NADH + H
In this scheme enz represent the respective decarboxylase,a,b,c,
acyl transferase and lipoyl dehydrogenase components of the 
complex, lip indicates the carboxyl terminus of lipoic acid,
TPP represents the prosthetic group thiamine pyrophosphate, and 
the various carbon skeletons of the keto acids are designated by 












FAD and FADH^ represent the oxidized and reduced forms of flavin
adenine dinucleotide respectively.
1+
Recently the obligatory participation of CoA and NAD+ has been 
observed in the enzymic oxidative decarboxylation of KMV, KIC and 
KIV by extracts of Bacillus subtilus (10) and rat liver (11). 
Evidence for the active participation of the other presumptive 
cofactors is largely indirect. Lipoic acid was determined to be 
essential for the oxidative decarboxylation of KMV and KIV in 
Streptococcus faecalis cells harvested from a lipoic acid deficient 
medium (12), and added thiamine pyrophosphate resulted in slightly 
increased KMV dehydrogenase activity in B, subtilus extracts (10). 
Direct evidence for the function of lipoic acid and thiamine 
pyrophosphate as prosthetic groups of the branched-chain cn-keto 
acid dehydrogenase systems of mammalian tissues has not been 
available.
Liver and kidney possess the highest branched-chain a-keto 
acid dehydrogenase activity in the rat (11); low levels were 
observed in heart and brain tissue, and no oxidative decarboxylation 
of these compounds was obtained from preparations of skeletal 
muscle. A general survey of branched-chain keto acid oxidative 
decarboxylase capacity of several mammalian species (13) indicated 
that bovine liver homogenates catalyzed the oxidation of KIC at a 
substantial rate, with a specific activity higher than that of most 
other tissues studied.
Several aminotransferases which will accept branched-chain 
amino acids as a substrate have been reported. Such an instance 
occurs in Escherichia coli, where one valine-specific and two
leucine-accepting transaminase enzymes are indicated (l^). Taylor
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and Jenkins (15) have isolated an aminotransferase from pig heart 
cytosol which accepts leucine, isoleucine, valine or glutamic acid 
as the amino group donor, and the related a-keto acids, a-ketoiso- 
caproic acid, a-keto-(3-methylvaleric acid, a-ketoisovaleric acid 
and a-ketoglutaric acid as the amino group acceptor. Availability 
of amino group acceptor appears to be a possible rate-limiting 
step for the oxidative of L-valine (l6). These transaminases are 
generally located in the non-particulate fraction in mammalian 
cells (11).
Branched-chain ketoaciduria (BCKA), also known as "Maple 
Syrup Urine Disease" (MSUD) because of the characteristic odor of 
the urine and bodily secretions, is a metabolic error of genetic 
origin which involves the degradation of the amino acids leucine, 
isoleucine and valine. Menkes (17) first described this disease 
in a family in which four infants died within several weeks of 
birth. Characteristic symptoms observed were vomiting, muscular 
hypertonicity, and a penetrating "maple syrup" odor to the urine.
A subsequent report by Dane is (18) involved a similar event in 
which the infant died at 20 months of ge possessing the symptoms 
of maple syrup odor, brain damage and generalized lethr.rgy.
Analysis of plasma and urine revealed abnormally high concentrations 
of the branched-chain amino acids and their a-keto acid analogues. 
Numerous instances of the disease have since been reported (19).
Snyderman (19) and Westall (20) have successfully treated 
branched-chain ketoaciduric patients with dietary therapy, the mode 
of which consists of reduced and carefully balanced consumption of
6
- V; if ■'Si: : w .
branched-chain amino acids. This therapy is most likely to succeed 
in preventing the alterations of neurophysiology, and other 
characteristic symptoms, if begun in the first week of life. It 
thus appears that the neonatal brain is particularly sensitive to 
high levels of branched-chain amino or a-keto acids.
Dancis (18,21,22,23*24) has proposed that the metabolic lesion 
effecting a block in the catabolism of the branched-chain amino 
acids and responsible for the genetic anomaly BCKA is a lack of, 
or a malfunction of, the enzyme or enzymes responsible for the 
catalysis of the oxidative decarboxylation of the branched**chain 
a-keto acids KIC, KMV, and KIV (refer toequation 2 above). Normal 
function of the transaminase enzymes has been observed in tissues 
of these individuals (25)«
In an attempt to clarify further the nature of the impairment 
in branched-chain amino acid metabolism in BCKA, a general aim 
of several investigations (22,26,27) has been to determine whether 
three specific dehydrogenase enzyme complexes are responsible for 
the oxidation of KIC, KMV and KIV, or whether a single less 
specific enzyme complex may catalyze the catabolism of all three 
keto acids. This question is of general interest, since the answer 
could provide significant information concerning the regulation of 
these metabolic pathways, and give pertinent insight bearing on 
the comprehension of the associated genetically determined metabolic 
disease. Current information would indicate that one of four major 
possible occurrences could account for the observed branched-chain 
amino acid and keto acids at elevated levels as noted in the
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diseased (BCKA) patient.A . All of the branched-chain a-keto acids are oxidized 
by one enzyme, which is genetically altered (22).
B. Each branched-chain a-keto acid is catabolized by a 
separate dehydrogenase of which all are malfunctioning (26).
C. Each branched-chain a-keto acid is acted upon by a 
separate enzyme, only one of which is genetically altered.
The resulting accumulation of intermediates acts to 
hamper the activity of the other two enzymes.
D. Two of the a-keto acids (KMV and KIC) may be catabolized 
by one enzyme, the activity of which may be affected by a 
genetic lesion, with a resulting increase in the 
concentrations of KMV and KIC in the cell acting to 
inhibit the metabolism of the third branched-chain a- 
keto acid, KIV (27).
M o m s  (28,29) and Dane is (23) have observed a variant form 
of BCKA which is not necessarily fatal and does not appear to result 
in significant mental retardation. They suggest that these 
individuals may possess a partial enzymic defect, since the 
peripheral leukocytes exhibited some decarboxylative activity with 
the branched-chain a-keto acids, as compared to the complete absence 
of branched-chain a-keto acid oxidative capacity in leukocytes 
obtained from patients with the classic branched-chain ketoaciduria. 
These investigators speculate that an entire spectrum of branched- 
chain a-keto acid dehydrogenase activities may be present in the 
general population; ranging from absence of the decarboxylase
8
activity in the classic BCKA individual to the full enzyme 
complement in normal tissues. Harris (30) has presented 
significant data with respect to a similar occurrence among certain 
other enzymes in the red blood cell.
Since the discovery of branched-chain ketoaciduria in humans, 
a number of investigators have proposed possible modes of action 
whereby the elevated levels of the branched-chain amino and keto 
acids may produce the observed physiological and neurological 
symptoms. Observations on patients undergoing dietary treatment 
have demonstrated that the acute symptoms (ataxia, convulsions) 
appear to be more closely related to elevated levels of leucine 
than of isoleucine or valine (31,32).
Tanaka, e_t a_l. (33) have recently obtained evidence for a 
new disorder of leucine metabolism, isovaleric acidemia, in which 
there is a defect in the further catabolism of isovaleryl-CoA, 
the oxidative product of KIC degradation. This metabolic error 
results in the accumulation of isovaleric acid, formed by 
deacylation of isovaleryl-CoA, in plasma and urine. Symptoms of 
the disease, in addition to the elevated plasma levels of iso­
valeric acid, included ata.via and loss of muscle coordination.
No increase in the serum concentrations of the branched-chain amino 
acids or a-keto acids was noted. The fact that leucine and KIC 
were not significantly increased in the plasma of the patients would 
probably be explained by the apparent irreversibility of KIC 
oxidative decarboxylation.
Autopsy examinations of several diseased BCKA patients have 
been described (16,3̂ +) in which similarities were observed with
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respect to a striking deficiency of myelination in certain primitive 
areas of the brain, and a spongy character to the white matter.
The absence of degradation products of myelin suggested that the 
lack of myelination resulted from an interruption of the synthesis 
normally occurring after birth. Silberman, et al. (3̂ +) have 
suggested that increased keto acid concentrations in the developing 
brain may decrease the synthesis of cerebronic acids, considerable 
amounts of which are necessary components of myelin. However, 
there is no suggestion that these findings are a direct and 
quantitative effect of the elevated leucine, isoleucine, valine or 
their corresponding keto acids. Howell (35) found that KIC and KIV 
were able to inhibit oxygen consumption by brain slices, and 
postulated that this phenomenon could account for the impaired 
function of this tissue in BCKA. The findings of Tashian (36) 
lend support to these data.
There has been considerable discussion regarding a possible 
site of inhibition by the abnormal accumulation of metabolites 
proximal to the metabolic block. Among these reports are the 
observations that various levels of branched-chain a-keto acids 
tend to inhibit the activity of glutamic acid decarboxylase in 
brain and liver of the rat (35 >36,37).» as weH  as more recent 
indications that this enzyme is not significantly affected by KIC 
concentrations below 1.0 mM. Decarboxylation of glutamic acid 
produces gamma-aminobutyric acid (GABA) which may participate 
in the process of transmission by inhibitory neurons (36).
Another possible mechanism of toxicity of the branched-chain 
amino and keto acids is inhibition by these compounds at the'level
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of pyruvate dehydrogenase in the glycolytic pathway, or at a- 
ketoglutarate dehydrogenase of the tricarboxylic acid cycle.
Recently Kanzaki (38) has found that the activity of a-ketoglutarate 
dehydrogenase purified from pig heart muscle is inhibited by KIC,KMV and KIV. Pyruvate dehydrogenase isolated from the same tissue 
source was inhibited by KMV and KIV; however the effects of KIC as 
an inhibitor of the purified pyruvate dehydrogenase complex were not 
discussed. Other investigators (37) have studied the inhibition of 
pyruvate dehydrogenase by the branched-chain a-keto acids from a 
semi-quantitative viewpoint, and have reported varying degrees of 
inhibition by KIC in rat brain and liver homogenates (13*37) anĉ 
in rat liver slice preparations (39)•
These preliminary observations indicate a necessity for further 
investigation into the mode and the extent of the effects of 
branched-chain a-keto acids, at the concentrations obtained during 
normal metabolism and in manifestations of BCKA, upon these two 
very important segments of intermediary metabolism. Since the 
glycolytic pathway and the tricarboxylic acid cycle are considered 
to be of fundamental importance to the provision of energy 
equivalents in the form of the reduced nucleotide coenzymes, a 
disruption of function at either site could conceivably be of 
serious consequence to the cell in terms of general oxidation 
state and in production of energy necessary for anabolic processes. 
Decreased pyruvate dehydrogenase activity would also result in 
lowered production of acetyl-coenzyme A for the tricarboxylic 
acid cycle and for fatty acid and steroid synthesis.
11
Leucine and alloisoleucine have been observed to inhibit 
gluconeogenesis slightly in concentrations in 1.0 mM (1+0,1+1). 
Instances of hypoglycemia induced by high levels of leucine have 
also been reported (1+2).
From the viewpoint of regulatory interrelationships among 
the keto acids the metabolism of branched-chain amino and keto 
acids in normal tissue has received less attention than has the 
pathology of the diseased tissues of the individual with B CK A .
An apparent antagonism among the branched-chain amino acids 
has been noted by Harper et al. (1+3) and by Snyderman (32). This 
antagonism is expressed as an imbalance in the ratios of plasma 
leucine, isoleucine and valine, resulting in decreased rates of 
growth in rats. Wohlheuter and Harper (11) have reported an 
increased rate of branched-chain a-keto acid dehydrogenase activity 
in rats fed a 30 per cent casein diet, or a diet containing nine 
per cent casein plus additional amino acids. Tito general types of 
increased activity were noted, one of which could be blocked by 
cycloheximide. A diurnal variation in branched-chain a-keto acid 
dehydrogenase activity was also noted.
The above phenomena suggest that there may be mutual metabolic 
interrelationships among branched-chain amino acid a-keto acids 
which are not obvious merely from a consideration of the individual 
degradative pathways.
STATEMENT ur rkOBLEM
The aim of the present investigation is to characterize the 
utilization of and the i_n vitro metabolic interrelationships among
. ’ ^  •* ‘ 'v “ ' > ‘
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the branched-chain a-keto acids in preparations of bovine liver 
tissue; and secondly, to ascertain whether the influences of 
branched-chain a-keto acids upon the metabolism of pyruvate and a- 
ketoglutarate could constitute a significant physiological 
regulatory phenomenon. Among the specific aspects of the above 
primary objectives considered in this study are the elucidation 
of the apparent location of the branched-chain a-keto acid 
dehydrogenase activities in the bovine liver cell and an investigation 
of the apparent requirements for coenzymes. Data pertaining to 
the determination of the number of enzymes responsible for the 
catalysis of the oxidative decarboxylation of a-ketoisocaproate, 
a-keto-p-methylvalerate, a-ketoisovalerate, a-ketoglutarate and 
pyruvate are presented. An attempt has been made to determine and 
to describe the relative extent and the apparent mode of inhibitory 
interactions among these metabolites.
The results of these investigations are discussed in relation 
to the cellular levels reported for these a-keto acids in normal 
tissues and with respect to the observed elevation of KIC, KMV 




The chemicals used in these studies were obtained from the 
following sources: f3-nicotinamide adenine dinucleotide (NAD+); 
trilithium coenzyme A; sodium salts of a-ketoisocaproate, a- 
ketoisovalerate, cn-keto-p-methylvalerate, a-ketobutyrate, a- 
ketoglutarate, a~ketovalerate, a-ketocaproate, pyruvate, succinate, 
malate, pyruvate and D,L-a-glycerophosphate; L-amino acid oxidase; 
D-amino acid oxidase; Dowex 50-W (200-i+00 mesh) ion exchange resin; 
Sephadex G-25 gel beads; triethanolamine-hydrochloride; antimycin A; 
oiigomycin; protamine sulfate; L-cysteine; nicotinamide adenine 
dinucleotide phosphate (NADP+); para-chloromercurisulfonate; bovine 
serum albumin; D,L-a-lipoic acid, thiamine pyrophosphate; flavin 
adenine dinucleotide (FAD); flavin nonucleotide (FMN); catalase;
/ \ ll+digitonin; (Sigma Chemical Co., St. Louis, Missouri); L-leucine-1- C,
lij. 1^. lipDL-valine-1- C, sodium pyruvate-1- C, sodium a-ketoglutarate-1- C,
(New England Nuclear, Boston, Massachusetts) ; L-isoleucine-U-^C
(Cal-Atomic Division, Calbiochem Co., Los Angeles, California);
l,4-bis-2-(5“phenyloxazolyl)-benzene (POPOP), 2,5 diphenyloxazole
(PPO), hydroxide of hyamine 10-X, low potassium glass scintillation
vials (Packard Instrument Co., Downers Grove, Illinois); 2,k
dinitrophenylhydrazine, ethylene diamine tetraacetate (disodium
salt), hexyl alcohol (Eastman Organic, Rochester, New York); 2,6
dichlorobenzone indophenol, urea, sodium arsenite, potassium
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ferricyanide, Folin-Ciocalteau phenol reagent, monobasic sodium 
phosphate, dibasic sodium phosphate, monobasic potassium phosphate, 
dibasic potassium phosphate, calcium chloride, sodium carbonate, 
magnesium chloride and other analytical reagent grade chemicals 
(Baker Chemical Co., Chicago, Illinois); mannitol, ammonium 
acetate, acetone, charcoal (Mallinkrodt Chemical Works, St. Louis, 
Missouri); toluene, sucrose (Fisher Scientific Co., Chicago,
Illinois); Triton X-IOO (Ruhm and Haas, Philadelphia, Pennsylvania); 
iso-amyl alcohol (Matheson, Coleman and Bell, Norwood, Ohio); 
adenosine triphosphate (P-L Biochemicals, Milwaukee, Wisconsin); 
EDTA-recrystallized ammonium sulfate (Mann Research Biochemicals, 
New York, New York); Blue Dextran 2000 (Pharmacia, Uppsala, Sweden); 
Bio-Gel P-2 (BioRad, Richmond, California). All other chemicals 
were of analytical reagent grade.
a-Ketoisocaproate-l-^\: (sodium salt), a-ketoisovalerate-1-^C 
(sodium salt) and a-keto-f3~methylvalerate (sodium salt) were 
synthesized from the appropriate labeled amino acids prior to use 
as described below. All water used in these studies was distilled 
and deionized (Corning 3508A double bed resin). Detailed methods 
for preparation of solutions of reagents are shown in Appendix I.
1^Preparation of C-labeled u-Keto Acids 
Carbon-l4-carboxyl-labeled a-keto acids were prepared with 
modifications of the method of Meister (44). L-amino acids are 
oxidized to the corresponding a-keto acids by L-amino acid oxidase 
in the presence of catalase. After removal of protein the a-keto 
acids can be purified by ion exchange chromatography and isolated
14
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as the crystalline sodium salt.
Snake venom L-amino acid oxidase (300 mg) dissolved in 20 ml 
of water is dialyzed against running water at 5°C for 12~2b hours. 
Crystalline bovine liver catalase is also dialyzed against 
running water at 5°C for 12 hours to remove preservative.
Two grams of the L-amino acid are suspended in 50 ml of water,
14to which is also added 50-100 microcuries of C-labeled amino 
acid, catalase (100 units) and the L-amino acid oxidase. The 
solution is adjusted to pH J.2 with 0.5 N NaOH and the volume 
brought to 100 ml with distilled water. One ml of hexyl alcohol 
's added to prevent foaming, and oxygen gas is bubbled continuously 
through the mixture. The reaction is allowed to continue at 37°0 
for S~2k hours, or until keto acid analyses (spectrophotometnc 
measurement of dinitrophenylhydrazone derivatives) indicate no 
further increase in a-keto acid formation. The pH of the solution 
is adjusted to pH "J.2 with 0.5 N NaOH as needed.
The a-keto acid is separated from protein by gel filtration 
of the reaction mixture on a Sephadex G-25 column (3 cm x 5̂ cm) 
at a flow rate of 1.0 ml per minute. Collected fractions were 
analyzed for radioactivity by liquid scintillation spectrometry 
and for protein by spectrophotometric determination of relative 
absorbance at 260 and 280 nm in a Beckman Model DU-2 multiple 
sample spectrophotometer. Complete separation of protein from 
radioactivity was obtained. Highest activity fractions (90-95 
per cent of total radioactivity) were combined and evaporated in 
a reduced pressure distillation apparatus at 26 mm pressure and
16
35°C. The concentrated solution thus obtained was passed through a 
Dowex 50-W cation exchange resin (H+ form), and the a-keto acid 
eluted with water at a flow rate of 0.5 til per minute. All 
fractions were analyzed for amino acid with ninhydrin reagent 
and for radioactive label by liquid scintillation spectrometry. 
Fractions containing 90-100 per cent of remaining radioactivity and 
no amino acid contaminant were combined, adjusted to pH 4.5 with 
5 N NaOH, and evaporated to a volume of less than 10 ml under 
reduced pressure.
Fifty to sixty volumes of ice-cold acetone were added slowly 
and the sodium salt of the cc-keto acid allowed to crystallize at 
0°C. The crystals were filtered over reduced pressure, 
recrystallized from concentrated aqueous solution by addition of 
ice-cold acetone, filtered and washed with acetone followed by dry 
diethyl ether on the filter. The crystalline sodium salt of the 
a-keto acid was then dried in a vacuum dessicator over sodium 
sulfate. Radiochemical purity of the compounds was ascertained by 
chromatographic (4-5) and spectrophotometric (45) determination, 
using the 2,4-dinitrophenyi hydrazone derivatives (45)* 2,4-
Dinitrophenyl hydrazine (0.1$ solution in 2N hydrochloric acid) 
was mixed in a slight volume excess with a sample of an aqueous 
solution of the a-keto acid to be analyzed. The crystals of the 
2,4-dinitrophenyl hydrazone derivative were allowed to form in 
the dark. These crystals were recrystallized from hot water, 
dissolved in ethanol (95%) and chromatogrammed on thin-layer silica 
gel plates. The values were determined after development of the
plates, and compared to values for the known a-keto acid 
derivatives.
The chromatogram spots were eluted into 0.5 N NaOH and spectra 
recorded from 700 nm to 350 nm on a Cary Model 15 recording spectro­
photometer. These spectra were then compared with those of pure a- 
keto acid 2,4-dinitrophenylhydrazone derivatives.
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Enzyme Assay Methods
A. a-Keto acid dehydrogenase activities were estimated using
modifications of the methods utilized by Wohlheuter and Harper (11)
and by Snyder (46), in which the amount of labeled carbon dioxide
evolved from carboxyl-labeled a-keto acids is measured after
incubation with various tissue preparations. The final reaction
volume of 1.0 ml usually contained the following constituents,
in micromoles: f3-NAD+, 1.0; Li^ CoA, 0.6; potassium phosphate
buffer, pH 7.2, 33; manniu.l, 150; CaC^, 1.0; MgCl^, 1.0;
14Na^CO^j 1.0; appropriate amounts of a-keto acid-1- C substrate, 
enzyme (2~3 mg protein), and water to 1.0 ml. The reactions were 
generally initiated by addition of enzyme by pipette. Flasks were 
capped immediately and swirled gently to facilitate mixing.
Warburg flasks, or small Erlenmeyer flasks with a center 
well, served as reaction vessels (Figure l). A small test tube 
(10 mm x 20 mm) containing 0.5 ml of hydroxide of Hyamine 10X 
was placed on the center well and the flask was tightly capped 
v/ith a rubber serum cap. The reactions were allowed to proceed 
for 20 minutes, or other specified time interval, at 30°C in a
shaking water bath, after which time 0,2 ml of 2.0 N sulfuric acid
Fig. 1.
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- Diagram of Incubation Flask used for Assay
Incubation flask
rubber cap 




was added to the reaction mixture by syringe through the rubber cap.
The acid stopped the enrymic reaction and released the dissolved
lii 14CO^ from solution. Distillation of CO^ into the Hyamine was
allowed to continue, with shaking, for one additional hour, at
which time the tube and its contents was transferred to a
scintillation vial containing 10 ml of a scintillation fluid /O.U °]o
2,5"diphenyloxazole, 0.01 %, 1,if bis-2-('5-phenyloxazolyl)-benzene,
in toluene, w/v/, and counted three times for 10 minutes in a
Packard Tri-Carb liquid scintillation spectrometer (Automatic
Model 500-E). The following settings were employed: 9̂ -0 volts,
100 per cent gain. The average background was 30 counts per
minute (cpm). Samples were run in duplicate or in triplicate.
Blank values were determined by carrying boiled enzyme preparations
through an identical procedure. Blank values of 10 to 30 cPm above
background were consistently observed for any one a-keto acid
14preparation, possibly resulting from traces of CC^ in the a-keto 
solutions and a slow non-enzymatic decarboxylation. Typical 
assays measured in the range of 500 to 1500 cpm. The amount of CO^ 
produced was calculated from the specific activity of the carboxyl 
labeled 1-^C-substrate. Results are expressed in units, defined 
as nanomoles of CO^ per minute; specific enzyme activity is 
expressed as units per mg of protein.
A modification of the above procedure, utilizing ferricyanide 
as an artificial electron acceptor, was also investigated and found 
to be a less sensitive measure of a-keto acid oxidation. A 
comparison of the two methods is shown in Figure 2.
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Fig, 2. —  Comparison of NAD+ and ferricyanide as electron 
li|acceptors for the COg assay of a-keto acid dehydrogenases
14 14The amount of CO^ evolved from a-ketoisocaproate-l- C in the presence
of a washed preparation of bovine liver mitochondria during a 20 min
incubation period at 30° C was measured with either NAD+ or ferricyanide
as the electron acceptor for the oxidation reaction. Each reaction
mixture contained, in a final volume of 1,0 ml, the following (in pmoles)
mannitol, 150; potassium phosphate buffer, pH 7*2, 335 MgC1̂ , 1.0;
CaC1?, 1.0; Na^CO^j 1.0; NAD+, 1.0, and Li^CoA, 0.6; or K^Fe(CN)g ,  0.05;
l-^C-KIC, 2.0 (3700 cpm per pinole); and the indicated quantities of
enzyme solution as shown on the figure.

23B . a-Ketoglutarate dehydrogenase purified from pig heart 
muscle was assayed by the modification of the method of Searles and 
Sanadi (1+7), in which the formation of NADH with time was measured
at 31+0 run on the Cary 15 or the Beckman Model DK-2 dual beam recording
s p e c t r o p h o t o m e t e r .  A m o l a r  e x t i n c t i o n  c o e f f i c i e n t ,  E o f’ max 340'’
3 -1 -16.22 x 10J M cm is assumed (8) for NADH in the calculation of 
enzyme catalytic rates. A typical reaction mixture contained the 
following components, in micromoles: potassium phosphate buffer, 
pH 7*2, 75; 3-NAD_r, 0.5; Li^CoA, 0.6; cysteine, 5*0; a-ketoglutarate, 
0.1 to 5*0; the appropriate quantity of enzyme solution, and water 
to a final volume of 1.5 ml in a 1 cm cuvette. A cuvette containing 
potassium phosphate buffer instead of enzyme, with all other 
reaction components present, was used as a reference. One unit of 
enzyme is defined as that quantity which will catalyze the formation 
of one micromole of NADH per minute. The stoichiometry of the 
reaction is such that one micromole of NADH formed is equivalent 
to oxidation of one micromole of a-ketoglutarate to products.
T h i s  a s s a y  s y s t e m  w as a l s o  e m p l o y e d  t o  m e a s u r e  o x i d a t i v e  
d e c a r b o x y l a t i o n  o f  o t h e r  a - k e t o  a c i d s  ( K I C ,  K I V ,  KMV) b y  p a r t i a l l y  
p u r i f i e d  e n z y m e  p r e p a r a t i o n s ;  h o w e v e r ,  t h i s  s y s t e m  i s  n o t  
g e n e r a l l y  s a t i s f a c t o r y  w i t h  p r e p a r a t i o n s  c o n t a i n i n g  s i g n i f i c a n t  
l e v e l s  o f  NADH o x i d a s e  o r  f o r  t h e  a s s a y  o f  h i g h l y  t u r b i d  e n z y m e  p r e p a r a t i o n s .
C .  T h e  a r t i f i c i a l  e l e c t r o n  a c c e p t o r s  d i c h l o r o p h e n o l  i n d o p h e n o l  
( DC P I P )  a n d  f e r r i c y a n i d e  h a v e  b e e n  sh o w n  t o  o x i d i z e  a - h y d r o x y e t h y l -  t h i a m i n e  p y r o p h o s p h a t e  t o  t h e  a c y l - t h i a m i n e  p y r o p h o s p h a t e
intermediate (8). Gubler (48) has described a continuous assay
which involves following the reduction of ferricyanide (Fe(CN)g )
with time at 420 nm as a measure of the decarboxylation of a-keto
acids by suspensions of mitochondria. A typical reaction, mixture
contained the following components in pmoles, in a calibrated
mixing tube: potassium phosphate buffer, pH 7*2, 150; ATP, 6.0;
EDTA, 7.0; MgSO^, 20; TPP, 0.5; K^Fe(CN)^, 3.34; a suitable amount
of enzyme preparation, and 0.25 M sucrose to a final volume of
6.8 ml. These constituents were mixed by inversion and divided
equally between two 1-cm matched cuvettes. The Cary Model 15
recording spectrophotometer was balanced to zero with the cuvettes
in position, at which time the substrate in a volume of 0.1 ml was
added to the reference cell, mixed rapidly by inversion, and the
3 -1 -1recording begun immediately. Emaxlt20 of 1>05 x 10 M cm iS 
assumed (13) for FefcN)^ \  The slope of the line traced over a 
100 second time interval is assumed to correspond to iimoles of 
a-keto acid oxidized in one minute.
D. Succinate dehydrogenase was measured according to the 
method of Bonner (49) by following ferricyanide reduction at 412 nm 
in a Cary Model 15 dual beam recording spectrophotometer.
E. Glycerol-l-phosphate dehydrogenase activity of washed 
preparations of liver mitochondria was determined by the method 
of Klingenberg (50), in which reduction of ferricyanide at 412 nm 
is followed on a Cary Model 15 recording spectrophotometer.
F. Glucose-6-phosphate phosphohydrolase activities were
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determined by the revised method of Nordlie and Arion (51)•
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" F e r r i c y a n i d e  L o c a l i z a t i o n "  o f  E n z y m e  A c t i v i t yI t  h a s  b e e n  sh o w n  (50) t h a t  som e m i t o c h o n d r i a l  e n z y m e s  (e_._g . 
C t - g l y c e r o p h o s p h a t e  d e h y d r o g e n a s e )  a r e  d i r e c t l y  a c c e s s i b l e  t o  
f e r r i c y a n i d e  a s  a n  e l e c t r o n  a c c e p t o r ,  w h i l e  o t h e r s  (e_._g,. s u c c i n a t e  
d e h y d r o g e n a s e )  a r e  n o t .  T h o s e  e n z y m e s  w h i c h  r e a c t  d i r e c t l y  w i t h  f e r r i c y a n i d e  a r e  c o n s i d e r e d  t o  b e  o n  t h e  o u t s i d e  o f  t h e  i n n e r  
m e m b r a n e ,  w h i l e  t h o s e  e n z y m e s  w h i c h  l i e  o n  t h e  m a t r i x  s i d e  o f  t h e  
i n n e r  m e m b ra n e  w i l l  n o t  r e a c t  d i r e c t l y  w i t h  f e r r i c y a n i d e .
Klingenberg (50) has shown, that ferricyanide does not penetrate the 
intact inner membrane. Spectrophotometric recording of optical 
density (420 nm) changes due to ferricyanide reduction was carried 
out in matched 1-cm cuvettes in a Cary Model 15 dual beam recording 
spectrophotometer. For this purpose mitochondria were suspended 
in a 0.3 M mannitol medium at a relatively low concentration (0.5 
to 1.0 mg protein per ml) with additions of 0.5 mM ferricyanide, 
substrates, and antimycin A  as indicated in the appropriate legends.
T h e  r e d u c t i o n  o f  f e r r i c y a n i d e  b y  t h o s e  s u b s t r a t e s  w h i c h  a r e  o x i d i z e d  o u t s i d e  o f  t h e  i n n e r  m e m b ra n e  i s  n o t  i n h i b i t e d  b y  
a n t i m y c i n  A  u n d e r  t h e s e  c o n d i t i o n s ,  w h i l e  r e d u c t i o n  o f  f e r r i c y a n i d e  
b y  s u b s t r a t e s  o x i d i z e d  i n s i d e  t h e  i n n e r  m e m b ra n e  i s  d e c r e a s e d  b y  t h e  
p r e s e n c e  o f  a n t i m y c i n  A i n  t h e  r e a c t i o n  m e d iu m . T h e  a n t i m y c i n  A 
s e n s i t i v i t y  o f  f e r r i c y a n i d e  r e d u c t i o n  b y  s u c c i n a t e  i s  a b o l i s h e d  
a f t e r  t h e  m i t o c h o n d r i a  h a v e  b e e n  f r a g m e n t e d  b y  s o n i c a t i o n  ( 5 0 , 5 2 ) .  
W h e r e  t h e  e f f e c t  o f  s o n i c a t i o n  w a s  s t u d i e d ,  t h e  f i n a l  m i t o c h o n d r i a l  
s u s p e n s i o n  w a s  s o n i c a t e d  f o r  20 s e c o n d s  a n d  u s e d  w i t h o u t  f u r t h e r  c e n t r i f u g a t i o n  i n  t h e  m e a s u r e m e n t  o f  f e r r i c y a n i d e  r e d u c t i o n .
2 6C i - K e t o  A c i d  P e r m e a t i o n  i n  M i t o c h o n d r i aT he general impermeability of the inner membrane of 
mitochondria toward various anions such as the branched-chain G- 
keto acids was estimated indirectly by following the rate of change 
in optical density at 515 nm of a mitochondrial suspension in the 
presence of high concentrations of the keto acid and of a cation 
which readily equilibrates across the membrane (53)- Such a 
permeable cation with an anion which is also permeable would result 
in rapid influx of water with the concomitant increase in 
mitochondrial volume (swelling).
I n  the typical swelling experiments the reactions were conducted 
in matched 1-cm cuvettes. The suspension of mitochondria was diluted 
with 0.3 M mannitol so that 0.1 ml of the suspension contained 
approximately 0.5 mg of protein. This amount of mitochondria in 
a total volume of 1,5 ml gave an optical density near 0.6 at 515 ran 
on a Cary Model 15 recording spectrophotometer, which was balanced 
to zero prior to addition of mitochondria. One-tenth ml of the 
suspension of mitochondria was added to the reaction cuvette and 
mixed rapidly. The optical density change with time was fol owed 
until swelling had occurred and the optical density had leveled 
off, or for a convenient time intervals. This spectrophotometric 
determination of swelling gives qualitatively reliable measurements 
of mitochondrial volume changes (5^).
E n z y m e  P r e p a r a t i o n s
Bovine liver mitochondria were prepared by a modification of 
the procedures utilized by Lusty and Singer (55)• Fresh bovine
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liver was obtained from the slaughter house, 10 to 15 gm of tissue
were placed in a pre-weighed beaker containing a solution of 0,3 M
-1+mannitol, which was 10 M with respect to EDTA, and minced with a
surgical scissors. The tissue was transported to the laboratory-
in this container, weighed and homogenized with approximately 10
-kvolumes of 0.3 M mannitol - 10 M EDTA in a Potter-Elvehjem
glass homogenizer. The crude homogenate thus obtained was then
centrifuged at 600 x £ for 10 minutes to remove cell debris and
nuclei. The supernatant fraction was decanted and saved. The
nuclear fraction (nuclei and cell debris) was resuspended in about
30 ml of 0.3 M mannitol - 10 ^ M EDTA and recentrifuged at 600 x £
for 10 minutes. The combined supernatant fractions were centrifuged
at 9,600 x £ for 10 minutes. The mitochondrial pellet was
-kresuspended in 0.3 M mannitol - 10 M EDTA and centrifuged at
9,600 x £ for 10 minutes. The resulting pellet was gently
—ksuspended in 0.3 M mannitol - 10 M EDTA to a final volume of 1,0 
ml per gram wet liver tissue. The protein concentration of this 
washed preparation of mitochondria varied from 23 to 28 mg per 
milliliter.
Further differential centrifugation procedures were utilized 
to obtain microsomal and soluble fractions. The supernatant 
fraction of the first 9,600 x £ spin was centrifuged at 80,000 x £ 
for one hour in a Beckman Spinco Model L preparative ultra­
centrifuge (number 30 head). The precipitate of this spin was 
termed the "microsomal fraction", and the supernatant fluid was 
denoted as the soluble or "supernatant" fraction.
4
Rat liver mitochondria preparations were obtained by techniques 
slightly modified from those utilized by Schneider (56). All rat 
liver mitochondria were obtained from male Sprague-Dawley rats 
(200 to 300 gm); the liver was removed immediately after 
decapitation and bleeding of the rat, blotted, placed in a preweighed 
beaker containing ice-cold 0.25 M sucrose and weighed. The liver 
was then finely minced with a stainless steel scissors in 
preparation for homogenization. The liver was homogenized in a 
Potter-Elvehjem glass vessel with a Teflon pestle. The ten tc 
fifteen grams of liver were homogenized in three equivalent portions 
of twenty-five to thirty ml of cold 0.25 M sucrose. The vessel and 
pestle were then rinsed in approximately ten ml of 0.25 M sucrose 
which was added to the homogenate to give a total volume of eighty 
to one hundred ml. The homogenate was centrifuged at 600 x 
for ten minutes in an International Model B-20 refrigerated 
centrifuge with the number 87O head, to remove blood cells, cell 
nuclei and other cell debris. The supernatant solution was decanted 
and saved. The "nuclear" residue was washed and homogenized with 
twenty ml of 0.25 M sucrose, centrifuged at 600 x for 10 minutes, 
and the supernatant decanted and saved. The combined supernatant 
fractions were centrifuged at 8,500 x for 10 minutes. The 
supernatant fraction which contained the microsomes was decanted 
carefully and discarded. The mitochondrial pellet was rehomogenized 
in thirty ml of cold 0.25 M sucrose and centrifuged at 8,500 x g 
for 10 minutes. The final pellet was suspended in 0.25 M sucrose 
to a volume equal to 1.0 ml per gram wet liver tissue. The protein
28
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concentration of this washed preparation of mitochondria varied 
from 25 to 30 mg per ml.
S o l u b i l i z a t i o n  b y  D i g i t o n i n  o f  O u t e r  M e m b ra n e  o f  M i t o c h o n d r i a
Treatment of isolated mitochondria with 1 per cent digitonin 
(w/v) solution has been shown to remove outer membrane and intra- 
membranal proteins from the inner membrane-matrix complex (57)•
An aliquot of a suspension of mitochondria containing 100 to 
160 mg of protein per ml is cooled in an ice bath. Cold 2 per 
cent digitonin (see Appendix i), in a volume equal to that of the 
mitochondrial suspension, is added. This suspension is incubated 
at 0°C for 20 minutes, then diluted with three volumes of cold
0.25 M sucrose or 0.3 M mannitol, and centrifuged for 10 minutes 
at 9^500 x £. The supernatant solution and the fluffy top layer 
of the precipitate are decanted. The solid precipitate consists 
mainly of inner membrane-matrix complex.
q - I C e t o g l u t a r a t e  D e h y d r o g e n a s e
Purified a-.ketoglutarate dehydrogenase was prepared from pig 
heart muscle by the methods of Sanadi, Littlefield and Bock (58)• 
Fresh pig heart (0.375 kg) is ground and homogenized for two 
minutes with 0.03 M potassium phosphate buffer, pH 7*2, in a 
Waring blender operating at full speed. This homogenate is then 
centrifuged at 2000 x for 30 minutes and the precipitate 
discarded. The supernatant is adjusted to pH 5»b with dropwise 
addition of 10 per cent acetic acid with continuous stirring.
This suspension is then centrifuged at 200 x _g for 20 minutes, the
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supernatant discarded, the precipitate washed in 75 mi of water
in a glass homogenizer, and recentrifuged for 10 minutes at i+Q00
x _g. The precipitate is suspended in 25 ml of water and adjusted
to pH 7*0 with 1.0 N NaOH. This suspension is then alternately
frozen and thawed four times, centrifuged for 20 minutes at
18,000 x £. Solid ammonium acetate (38.5 g) are then added per
100 ml of supernatant fluid, the suspension stirred an additional
^5 minutes, and then centrifuged for ten minutes at 18,000 x
T he precipitate is then dissolved in 2.5 ml of 0.02 M potassium
phosphate buffer, pH 7.2, dialyzed overnight against one liter of
“5the same buffer, and made 10 M with respec;- to L-cysteine. The 
final product is approximately three ml of fairly clear cream- 
colored solution which is stored frozen at -18°C. The recovery 
of enzyme activity is about 10 per cent of total homogenate 
activity with 200- to 250-fold purification.
Protein Determinations
Protein concentrations were measured by three different 
methods. The standard protein assay method used for these studies 
was the Biuret method (59) with bovine serum albumin (Armour 
Standard) as the protein standard. To three 0.1-ml samples of 
the protein preparation was added 0.1 ml of Triton-urea reagent 
(see Appendix i) and water to a volume of 1.0 ml. Biuret reagent 
(b.5 ml) was added to two of the three tubes and 1+.5 ml of a 3 
per cent sodium hydroxide solution was added to the third tube. 
Standard protein references and mannitol-EDTA blanks were assayed 
concurrently with the unknowns. Samples were allowed to stand for
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at least thirty minutes to allow for maximum color development.
T he o p t i c a l  d e n s i t y  o f  t h e  s o l u t i o n s  w e r e  t h e n  m e a s u r e d  o n  a  K l e t t -  
S u m m e rs o n  c o l o r i m e t e r  e q u i p p e d  w i t h  t h e  n u m b e r f i l t e r .  O p t i c a l  
d e n s i t y  r e a d i n g s  ( K l e t t  u n i t s )  o f  t h e  b l a n k s  w e r e  s u b t r a c t e d  f r o m  
a l l  r e a d i n g s  t o  g i v e  a c t u a l  o p t i c a l  d e n s i t y  c h a n g e s  d u e  t o  t h e  
p r e s e n c e  o f  t h e  p r o t e i n .  T h i s  m e t h o d  g i v e s  a  l i n e a r  r e l a t i o n s h i p  
b e t w e e n  a b s o r b a n c y  ( K l e t t  u n i t s )  a n d  p r o t e i n  c o n c e n t r a t i o n  w h e n  
t h e  a m o u n t  o f  p r o t e i n  a d d e d  i s  b e t w e e n  0.75 mg a n d  6.0 m g .  F o r  p r e p a r a t i o n  o f  s o l u t i o n s  s e e  A p p e n d i x  I .
T h e  L o w r y  p h e n o l  m e t h o d  (60) o f  p r o t e i n  c o n c e n t r a t i o n  
d e t e r m i n a t i o n  w as u t i l i z e d  a s  f o l l o w s :
Five ml of Reagent C, made up daily from 50 parts Reagent A 
and one part Reagent B, was added to all tubes (see Appendix I for 
preparation of reagents). One ml of protein solution was added 
to each of three tubes. The reagent blank contained water instead 
of protein. Color was developed by the addition of 0.5 ml of 
Folin-Ciocalteau phenol reagent (1.0 N with respect to culfuric 
acid) to two of these tubes. The third tube served as a color 
blank, to which 0.5 ml of water was added rather than the Folin- 
Ciocalteau phenol reagent. A protein standard, containing 100 
(ig of bovine serum albumin (Armour Standard), was assayed 
concurrently with the samples in the same manner. Klett 
colorimeter (equipped with a number 62 filter) readings of the 
blanks were subtracted from both unknown and standard protein 
solutions. The linearity of this method is maintained between 
10 jag and 150 pg of protein per ml of solution.
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For rapid determination of protein content of fractions 
obtained daring Sephadex G-25 gel filtration of the a-keto acid 
preparations the absorbancies at 260 nm and 280 nm were measured 
with a Beckman Model DU-2 spectrophotometer, and the protein 
concentrations calculated from these readings by the following 
formula:
Protein ( m g / m l)  =  1.1*5 E280nm - 0.7k
w h e r e  a n d  s i g n i f y  t h e  m o l a r  e x t i n c t i o n  o f  t h e  s o l u t i o n
a t  t h e  i n d i c a t e d  w a v e l e n g t h s  ( 6 1 ) .
RESULTS
Determination of Conditions for Assay of g-Keto 
Ac id Dehydrogenases
Prior to a kinetic evaluation of the more complex parameters 
of the interactions of a-keto acids in mammalian liver, it was 
necessary to establish baseline experimental conditions in order 
to ensure that subsequent studies would be conducted under 
standardized and optimal conditions. Since the enzymatic oxidative 
decarboxylation of five g-keto acids (KIC, KMV, KIV, KG, Pyr) 
was to be investigated, it was desirable to establish, as 
completely as possible, the essential components of the assay 
systems used to measure these enzyme activities.
The relationships between protein concentration and decarboxylase 
activity using carboxyl-labeled a-keto acid substrates are shown 
for a-ketoisovalerate (Figure 3)> a-ketoisocaproate (Figure 4), 
g-keto-p-methylvalerate (Figure 5), pyruvate (Figure 6), a-keto- 
glutarate (Figure 7). The production of ' 'COg from labeled a-keto 
acids was found to be linear with enzyme concentration to at least
6.0 mg of tissue preparation lot the branched-chain a-keto acid 
substrates and for a-ketoglutarate; pyruvate gave linearity to 
about lf.0 mg protein. Enzyme assays were conducted as described
in the legend, in the text and in the "Methods" section.
IkT h e  linear evolution of CO2 obtained with increasing time 
of incubation at 30°C is illustrated for a-ketoisovalerate
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Fig. 3. -- Formation of CO^ from a-ketoisovalerate as a 
function of protein concentration
The amounts of produced from KIV-1-^C with varied amounts of
14mitochondria or "supernatant" preparations was measured by the CO^ 
assay as described in the Methods section. Each reaction mixture 
contained in a final volume of 1.0 ml, the following (in micromoles) 
mannitol, 150; potassium phosphate buffer, pH 7*2, 33; NAD, 1.0; 
Li^CoA, 0.6; MgCl2, 1.0; CaCl2, 1.0; Na2C03, 1.0; l-ll+C-KIV, 2.0; 
and the indicated amounts of enzyme preparation. Mitochondria and 
"supernatant" fractions are described in the Methods section. All 
assays were conducted at 30°C for 10 minutes.
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Fig. k. —  Formation of CO^ from a-ketoisocaproate as a 
function of protein concentration
lip lipThe amounts of CO^ produced from 1- C-a-ketoisocaproate during
lipa 10 minute incubation period were measured by the CO^ assay. 
All reaction components and conditions are the same as those
stated for Fig. 3,- with the exception of a-keto acid substrate,











Fig. 5* ““ Formation of CO^ from a-keto-p-methylvalerate 
function of protein concentration
Ik"igure 5 shows the relative amounts of CO^ produced from carboxyl- 
Labeled KMV with varied amounts of the same washed preparation of 
povine liver mitochondria. The basic reaction mixture and assay 
procedures were as described in Figure 3 with the exception of 
substrate. 2.0 |jmoles of carboxyl-labeled KMV (2050 cpm. per 










Fig. 6. -- Formation of CO^ from pyruvate as a function 
of protein concentration
1*+Figure 6 shows the relative amounts of CO^ produced from carboxyl' 
labeled KMV with varied amounts of the same washed preparation of 
bovine liver mitochondria. The basic reaction mixture and assay 
procedures were as described in Figure 3> with the exception of 
substrate. 1.0 pinole of 1-^C-pyruvate 53,600 cpm per pinole was




Fig. 7. —  Formation of CO^ from CH-ketoglutarate as a function 
of protein concentration
II4 ]kThe amounts of C0o produced from a-ketoglutarate-l- C with
varied amounts of the same washed preparation of bovine liver
mitochondria are shown in Figure 7• The basic reaction mixture
and assay procedures were as described for Figure 3, with the
exception of a-keto acid suostrate. 1.0 pinole of carboxyl-labeled-KG
(50,000 cpm per pmole) was added to each reaction flask. Incubations




nanomofes COg /  minute
(Figure 8) , Ct-ketoisocaproate (Figure 9), a-keto-p-methylvalerate 
(Figure 10), pyruvate (Figure 11), and Ct-ketoglutarate (Figure 12). 
Some deviation from linearity with che longer incubation periods 
was noted, and for this reason appropriate linearity determinations 
were obtained with each set of experimental conditions preliminary 
to actual quantitative kinetic study.
Rates of oxidative decarboxylation of KIV, KIC, KMV, KG and 
pyruvate were measured at various pH values to determine the value 
for optimal assay conditions. The results of the effect of pH of 
the reaction medium upon the rate of ^ P 0 o production with carboxyl- 
labeled KIV, KMV and KIC as substrates are shown in Figure 13. The 
observed activity maxima were nearly identical. Maximal reaction 
rates with a-ketoglutarate and pyruvate were obtained at slightly 
lower pH values. The optimum pH for enzyme reaction with these 
substrates is observed to lie in a range of 6.8 to "J.1 for bovine 
liver mitochondria preparations. A pH value of 7'2 was chosen 
for all subsequent assays, since at this hydrogen ion concentration 
the rate of non-enzymatic decarboxylation was minimal and the 
enzymic activity was satisfactory with each of the a-keto acid 
substrates.
The coenzymes NAD', coenzyme A, TPP, FAD and lipoic acid have 
been shown to be essential in the oxidation of pyruvate and a- 
ketoglutarate by their respective enzyme complexes (8,9,62,63,64). 
Table I shows the relative effect of these and several other 
cofactors on the decarooxylation of a-ketoisocaproate by washed 
preparations of bovine-liver mitochondria. The activity of the
TABLE 1
EFFECTS OF SEVERAL COFACTORS ON a-KETOISOCAPROATE 
DEHYDROGENASE REACTION3
Reaction medium Relative activity
(per cent)
Complete-----------   100.0
minus N A D ----------------  11.7
minus CoA-----------------  8.6
minus MgCl^---------------- 69*0
minus CaCl^-”-- - ---------- 12.0
minus NAD”1", plus 0.5
micromole NADP+--------  8.3
plus 0.05 praole lipoate---  103.0
plus 0.5 pinole TPP--------  92.6
plus 2.0 pmoles of ATP----  29«0
plus 0.005 pinole of FAD---  95.0
plus 0.005 pinole of FMN---- 89*0
plus 1.0 pmole of CdCl^---  2.3
a liiKIG dehydrogenase activity was measured with the C09 assay as
described in the Methods. *
^The complete reaction mixture contained in a final volume of 1.0 
ml, the following, in pmoles: mannitol, 150; potassium 
phosphate buffer, pH 7*2, 33; NAD, 1.0; LioCoA, 0.6; MgClp, 1.0; 
CaCl-̂ , 1.0; Na2C02, 1.0; 1-^+C-KIC, 2.0; and 0.1 ml of a washed 
preparation of bovine liver mitochondria. Subtractions from or 
additions to the complete media were as indicated in the Table.
Fig. 8. —  Formation of CO^ from a-ketoisovalerate as a
function of incubation time
11+a-Ketoisovalerate dehydrogenase activity was measured by the CO^ 
assay as described in the Methods section. Each reaction mixture 
contained in a final volume of 1.0 ml the following (in micromoles) 
mannitol, 150; potassium phosphate buffer, pH 7.2, 33; NAD, 1.0; 
Li^CoA, 0.6; MgCl2, 1.0; CaCl2, 1.0; Na2C0^, 1.0; 0.1 ml of a 
washed preparation of bovine liver mitochondria, and 2.0 micromoles 




Fig. 9. —  Formation of CO^ from a-ketoisocaproate as a 
function of incubation time
Figure 9 shows the amounts of ^C-C^ evolved after various incubation 
times at 30°C from 1-^C-KIC. Each reaction mixture contained 0.1
ml of a washed preparation of bovine liver mitochondria, and 2.0
Ik . .pmoles of 1- C-KIC (3500 cpm per pinole). All other components 
of the reaction mixture, conditions, and assay procedures were 







Fig. 10. -- Formation of CO^ from a-keto-(3-methylvalerate
as a function of incubation time
illFigure 10 shows the amounts of CO^ evolved after various incubation
times at 30°C from carboxyl-labeled ^C-KMV (2050 cpm per pinole).
Each reaction mixture contained 0.1 ml of a washed preparation of
Ikbovine liver mitochondria, and 2.0 pmoles of C-KMV. All other 
conditions, reaction mixture components, and assay procedures were 
identical with those described in Figure 8.
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Fig. 11. -- Formation of CO^ from pyruvate as a function
of incubation time
lUThe amounts of CO^ evolved after various incubation times
1 |
at 30 C from 1- C-pyruvate (58,600 cpm per pmole) are shown in 
Figure 11. Each reaction mixture contained 0.05 ml of a washed
14preparation of bovine liver mitochondria, and 1.0 pinole of 1- C-pyr. 
All other conditions, reaction components, and assay procedures were 


















Fig. 12. -- Formation of CO^ from a-ketogluterate as a function 
of incubation time
llj.Figure 12 shows the amounts of CC^ evolved after various incubation 
times at 30°C from a-ketoglutarate-l-^C (50,000 cpm per pinole). Each 
reaction mixture contained 0.05 ml of a washed preparation of bovine
14liver mitochondria, and 1.0 pinole of 1- C-KG. All other conditions, 
reaction components, and assay procedures were as stated for Figure 8.
s o
Fig. 13. -- The relationship between pH and branched-chain 
a-keto acid dehydrogenase activities of bovine liver mitochondria
Assays were conducted at the pH values indicated in the Figure 13.
lifeQ-Keto acid dehydrogenase activities were measured with the COg 
assay. Other reaction components were as stated in the legend 
of Figure 3 with the exception of a-keto acid substrate. Initial 
a-keto acid concentration in each assay was 2.0 mM. Phosphate 
buffers were used throughout the entire range even though some 
buffering capacity is sacrificed at the low and high pH values.
( A ---A  ) KIV, ( g  —  H  ) KMV, ( $ --- @  ) KIC.
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mitochondrial enzyme which catalyzes this reaction is largely
dependent upon the presence of added NAD"1 and coenzyme A. Other
components of the standard assay medium which appear to promote
+2 +2optimal reaction rates are Mg , Ca and inorganic phosphate. The 
effects of are shown in a later figure, and the importance of 
these agents will be discussed in more detail below. Attempts to 
demonstrate a direct stoichiometric relationship between reduction 
of NAD+ and a-keto acid decarboxylacion have been thwarted by the 
generally high degree of opacity (at 3^0 nm) of reaction mixtures 
containing the particulate enzyme preparations, and by the variance 
of reoxidation of NADH by the crude preparations. Data of Table 1, 
however, support the earlier postulation, as outlined above 
(equations 2-7), that all of the components of the presumed 
dehydrogenase complex participate in the overall oxidative 
decarboxylation of the branched-chain a-keto acids by mammalian
-fliver mitochondria. It is apparent that NADP can not replace 
NAD+ as an electron acceptor in this reaction system. Addition of 
other presumptive cofactors such as TPP, lipoate and flavin 
derivatives produced no significant effect upon KIC oxidation. 
However, stimulation of the enzyme activity by these coenzymes would 
not be expected in consideration of the generally tightly-bound 
nature of these prosthetic groups with their protein apoenzyme 
moieties. Separation into free coenzyme and inactive apoenzyme 
usually requires rather rigorous physical or chemical procedures. 
These findings are in general agreement with those previously 
reported for the oxidation of KIV by extracts of B. subtilus (10)
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and for the decarboxylation of KIC by isolated rat liver 
mitochondria (11). v"-,. :>*,'■
An observation which was not entirely expected was that of 
the marked reduction of catalytic activity in the presence of ATP 
(2 mM). This apparent inhibitory effect and the stimulatory nature 
of inorganic phosphate in this system will be discussed in connection
with the possible existence of a kinase-phosphataie activating and
■’ ' :A..
de-activating system for the a-keto acid dehydrogenase complexes.
The results of a more thorough investigation of the effects of
+CoA and NAD on the branched-chain a-keto acid dehydrogenase
activities are shown in Figure 14 (KIC) and Figure 15 (KIV). These
requirements (with those for KMV oxidation) are summarized in
+Table 2. These data indicate that both NAD and CoA are essential 
to maintain maximal branched-chain a-keto acid oxidative capacity 
with washed preparations of mitochondria. On the other hand, 
decarboxylase activity of the supernatant fluid of tne 80,000 x g 
centrifugation procedure (preparation of enzyme, see "Methods") 
showed no apparent dependence on added CoA in the reaction medium.
The existence of an acyl-CoA hydrolase in the soluble fraction, 
similar to that demonstrated by Namba e_t al. (10) in B. subtilus 
preparations, conceivably could lessen the apparent need for 
exogenous CoA by allowing for the continued regeneration of 
catalytic amounts of the free coenzyme from acyl-CoA compounds 
present as contaminants in the enzyme preparation.
A second possibility, which can not be excluded at present, is 
that the supernatant fluid may contain a decarboxylase specific for
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TABLE 2
EFFECTS OF ADDED NAD+ AND CoA ON BRANCHED-CHAIN a-KETO
ACID DEHYDROGENASE ACTIVITIES OF MITOCHONDRIA AND
SUPERNATANT FRACTIONS OF BOVINE LIVER3
Enzyme preparation
Reac tion mixture





mitochondria-- 1.7^ 0.16 0.26 0.06
supernatant--- 0.11 0.12 0.05 0.05
a-Keto-p-methylvalerate 
dehydrogenase:
mitochondria-- 3.20 0.29 0.39 0.11+
supernatant--- 0.2Q 0.23 0.17 0.13
OJ-Ke to iso vale rate 
dehydrogenase:
mitochondria-- 5.63 0.1+7 0.66 0.39
supernatant--- 0.03 0.03 0.01 0.01
clBraached-chaia a-keto acid dehydrogenase activity was measured 
with the ^CO^ assay as described in the Methods.
The complete reaction mixture contained the following components, 
in a final volume of one ml, in ^moles: mannitol, 150; potassium 
phosphate buffer, pH 7.2, 33> N A D , 1.0; Li^CoA, 0.6; MgCl2, 1.0; 
CaCl2, 1.0; Na2C0o, 1.0; 0.1 ml of enzyme preparation and 2.0 
pmoles of carboxyl-labeled a-keto acid. Subtractions from the 
complete media were as indicated in the Table.
Fig. 14. -- Effects of added NAD and CoA upon a-ketoiso- 
caproate oxidation
KIC dehydrogenase activity was measured by the ^ C 0 2 assay as 
described in the Methods section. Each reaction mixture contained 
in a final volume of 1.0 ml, the following constituents (in 
micromoles): mannitol, 150; potassium phosphate buffer, pH 7*2,
335 MgCl2, 1.0; CaCl2, 1.0; Nfi^CO^ 1.0; l-ll+C-KIC, 2.0 (36OO
cpm per micromole); 0.1 ml of a washed preparation of bovine liver
mitochondria (2.4 mg protein), or 0.2 ml of bovine liver "supernatant"
fraction (2.1 mg protein); 0.6 micromole Li^CoA, and 1.0 micromole 
NAD where indicated. The "supernatant" fraction referred to is the 
supernatant of the 80,000 x centrifuge spin as described in the 
Methods section under "enzyme preparations'1. Reactions were allowed 
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Fig. 15. —  Effect of added NAD and CoA on the rate of CC^ 
production from a-ketoisovalerate by bovine liver mitochondria
KIV dehydrogenase activity was measured by the assay as
described in the Methods. Additions of NAD, CoA and enzyme 
preparations were as stated for Figure lb, Each reaction mixture 
contained 2.0 pmoles of 1-^C-KIV (3700 cPm Per nmole). All ( her 
conditions, reaction components, and assay procedures were as 
stated for Figure l!+.
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the branched-chain a-keto acids, which does not require coenzyme A
as a component of its catalytic process. The data of Table 2 also
disclose that the supernatant enzyme activity is significantly
higher with KMV and KIC as substrates, than for KIV. This
represents a decided variance from the activity ratios observed
for the mitochondrial enzyme activities, where the rate of
decarboxylation was greatest with KIV as the a-keto acid substrate.
The following studies were initiated in an attempt to
elucidate to what extent the rate of branched-chain a-keto acid
decarboxylation was affected by varied concentrations of NAD+ and CoA.
IkThe effects on evoluti- i of CO^ from carboxyl-label c KIC were 
studied in detail. An apparent Michaelis constant for NAD+ of
“53.2 x 10 M was calculated from the reciprocal plots shown in
Figure 16. The Lineweaver-Burk plot in Figure 1J illustrates the
rfect of varied CoA concentrations on KIC oxidation by bovine liver
mitochondria. Apparent inhibition by CoA was observed with
-qconcentrations above 10 M, with a calculated K value form
coenzyme A of 6.*4 x 10  ̂M.
Preliminary observations by this author and prior investigation 
by Hayakawa (65), Lusty and Singer (55) and Wohlheuter (ll) had 
indicated that the divalent cations Ca^+, Mg^+ and sometimes Mn^+ 
appeared to modify significantly the a-keto acid dehydrogenase 
activities. These effects were noted with purified enzyme 
preparations and with suspensions of mitochondria. Requirements 
of the branched-chain a-keto acid dehydrogenases for certain divalent 
cations are shown in Table 3* The dehydrogenase activities with 
each of the three branched-chain a-keto acids was strongly stimulated
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TABLE 3
EFFECTS OF ADDED MgCl^ CaCl2 AND MnCl2 IN THE REACTION MEDIUM 
ON THE BRANCHED-CHAIN a-KETO ACID DEHYDROGENASE ACTIVITIES 
OF BOVINE LIVER MITOCHONDRIA PREPARATIONS3
Enzyme and additions specific activity relative activity
(nanomoles/min/mg protein) (per cent)
Ct-Ke to is ocapro ate 
dehydrogenase:
Ca"2 Mg+2..... — -
Ca"' ”“+2.........
Mg
+2 +2 Mn+2 Ca_ Mg %  Mn -
c*' , +2 |̂n+2
none------ --- — —
a-Ke to iso valerate 
dehydrogenase:
Ca+§, „g+2........ .





































Branched-chain a-keto acid dehydrogenase activity was measured 
with the 1 ;C0? assay as described in the Methods, 
b ^Each reaction mixture contained the following, in pmoles; 
mannitol, 150; NAD, 1.0; Li-XoA, 0.6; Na2CCo., 1.0; carboxyl- 
labeled a-keto acid, 2.0; 07*1 ml of a washed preparation of 
bovine liver mitochondria, and 1.0 pinole of each divalent cation 
where indicated, in a final volume of 1.0 ml.
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Fig. 16. -- Lineweaver-Burk plot of KIC dehydrogenase activity 
as a function of NAD+ concentration
Ik lk +Lineweaver-Burk plots of CO^ evolution from 1- C-KIC with NAD
as varied coenzyme. KIC dehydrogenase activity was measured by
+ lUthe NAD - and CoASH-dependent CO^ assay as described in the Methods 
section. Each reaction mixture contained the following (in pmoles): 
mannitol, 150; potassium phosphate buffer, pH 7*2, 33i Li^CoA, 0.6; 
MgCl^, 1.0; Ca/Jl̂ , 1.0; Na^CO^ 1.0; the indicated amounts of 
NAD , and 0.1 ml of mitochondria suspension in a final volume of 
1.0 ml. (v^, nanomoles of CO^ produced per minute per mg of protein).
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Fig. 17. -- Lineweaver-Burk plot of the activity of a-ketoiso 
caproate dehydrogenase activity as a function of CoA concentration
IkKIC dehydrogenase activity was measured by the CO^ assay. All 
components of the reaction medium were the same as for Figure 16, 
except that 1.0 pinole of NAD was used^ and CoA concentration was 
varied as indicated in this Figure. (v^ nanomoles COg produced 
per minute per mg of protein).
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by added Ca^+ ; and to a lesser extent by exogenous Mg^'. The 
2+ 2+effects of Mg and Ca appear to be, additive, suggesting that
the activation by these two cations occurs by separate mechanisms.
2+In this regard It should be noted that An could apparently 
2 4 -replace the Mg requirement to a limited extent, but could not
24substitute for Ca . The relative rates of oxidation of KIC, KMV
and KIV were decreased by nearly identical amounts when exogenous
2 4  2+Mg , Ca or both cations were omitted from the reaction medium.
The effects of other divalent cations were not studied
,2 4systematically. However,- it was observed that 1.0 mM Cd completely
inhibited KIC decarboxylation.
The striking dependence of (branched-chain a-keto acid)
2 4oxidative decarboxylation on Ca and inorganic phosphate prompted
further study of their effects. Reciprocal plots illustrative of
the influence of varying amounts of added Ca (Figure 18) and P.
(Figure 19) are included. The exact nature of the non-linearity
of these plots is not understood at this time. Apparent affinity
constants of the order 1.0 mM for Ca^+ and 20 mM for P. can be1
estimated from these plots. It is of some general interest to note
4 2that these values approach the physiological levels found for Ca 
in mammalian liver mitochondria (66,67) and those calculated 
for inorganic phosphate in whole liver homogenates (68,,69)*
All CH-keto acid dehydrogenase assays to be described in the 
following studies were conducted under the optimal conditions 
based on the information reported above: 1.0 mM NAD+, 0.6 mM CoA;
1.0 mM CaCl^; 1.0 mM MgCl^; and 33 mM potassium phosphate buffer, 
pH J.2, Reaction incubations were carried out at 30°C for an
■
• / ■ v-
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Fig. 18. -- Effects of added CaCl on the KIV dehydrogenase 
activity of bovine liver mitochondria
Lineweaver-Burk and Michaelis-Menten plots of the effects of varied
+2 ll}- 14Ca concentration on evolution of CÔ , from 1- C-KIV are shown2
in Figure 18. KIV dehydrogenase activity was measured by the 
assay as described in the Methods. Reaction mixtures contained (in 
pinoles) : mannitol, 150; potassium phosphate buffer, pH 7*2, 33> NAD, 
1.0; Li^CoA, 0.6; MgCl2, 1.0; Na^O^, 1.0; 1-11+C-KIV (3500 cpm per 
pinole), 2.0; 0.1 ml of a washed preparation of bovine liver 
mitochondria, and the indicated amounts of CaCl2 in a final volume 
of 1.0 ml. (v^, nanomoles C02 produced per minute per mg of protein)
;.wrt;>
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Fig. 19. —  Effect of changes in orthophosphate concentration 
on the KIV dehydrogenase activity of bovine liver mitochondria
Lineweaver-Burk and Michaelis-Menten plots of the effects of
Ilf Ilfvaried concentration on evolution of CO  ̂from 1- C-KIV are
shown in Figure 19. Reaction mixtures, experimental conditions,
and assay procedures were as stated for Figure 18, except that P_̂
concentrations were varied, and 0.01 M triethanolamine hydrochloride,
pH 7.2, was used to maintain buffering capacity, and 1.0 pinole of





appropriate time interval dependent upon the extent of linearity 
obtained for the particular set of experimental conditions of 
the investigation. Any variation from these conditions is noted 
in the legend of tables and figures, or in the text.
Effeets of a-Keto Ac id Substrate Concentration on ■-Keto
Acid D e h y d r o g e n a s e  R e a c t i o n  R a t e s
Quantitative studies of the influence of substrate
concentration upon the rate of oxidation of the a-keto acids were
essential as a prerequisite to the investigation of mutual metabolic
interactions among these compounds. Apparent K values werem
determined for KIV, KMV, KIC, KG and pyruvate. Substrate effects
were investigated over at least a ten-fold variation of concentration
for each keto acid. The relationship between the reciprocal of
initial reaction velocity (v ) and the inverse of KIC concentration
is shown in the Lineweaver-Burk plot of Figure 20. The apparent Km
value for KIV calculated from these plots was 0.33 niM. The
information represented by the reciprocal plots of Figure 21
allows for determination of the apparent K for KMV, which ism
0.^7 mM. A Michaelis constant of 0.44 mM is obtained for KIC from 
the data illustrated by Figure 22. The experimental results which 
are included in double reciprocal ferm in Figure 23 show the 
apparently linear double reciprocal plots determined by variation 
of c-ketoglutarate concentration between 0.05 mM and 1.0 mM. It 
should be mentioned that significant deviation from linearity was 
observed at KG concentrations below 0.04 mM. This phenomenon may 
be due to the existence of the presumed permeability barrier to KG
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Fig. 20. —  Effect of varied a:-ketoisovalerate concentration 
on the rate of CO^ production by bovine liver mitochondria
Lineweaver-Burk plot of the activity of KIV dehydrogenase of bovine 
liver mitochondria as a function of substrate (KIV) concentration 
(v^, nanomoles of CO^ produced per minute per milligram of protein).
liiE n z y m e  a c t i v i t y  w a s m e a s u r e d  w i t h  t h e  C C ^  a s s a y  a s  d e s c r i b e d  i n  t h e
M e t h o d s  s e c t i o n .  E a c h  r e a c t i o n  m i x t u r e  c o n t a i n e d ,  i n  a  f i n a l  v o l u m e
of 1.0 ml, the following (in micromoles): mannitol, 150; potassium
phosphate buffer, pH 7.2, 33; NAD+, 1.0; Li^CoA, 0.6; MgCl,,, 1.0;
CaCl^, 1.0; Nâ CÔ ., 1.0; 0.1 ml of a washed preparation of bovine
1 er mitochondria (about 2.5 mg of protein), and the indicated amounts 
12+ . .or 1" C-KIV (3700 cpm per micromole). Reactions were allowed to 
proceed for 20 minutes at 30°C.
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Fig. 21. -- Effect of varied a-keto-|3-methylvalerate 
concentration on the rate of formation of CO^ by bovine liver 
mitochondria
Linewsaver-Burk plot of the activity of KMV dehydrogenase of bovine 
liver mitochondria as a function of substrate (KMV) concentration 
(v ^  nanomoles of CO^ produced per minute per mg of protein). Each 
reaction mixture contained 0.1 ml of a washed preparation of 
mitochondria and the indicated quantities of carboxyl-labeled KMV. 
All other experimental conditions, reaction components and assay 
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Fig. 22. -- Effect of varied a-ketoisocaproate concentrations 
on the rate of CC^ production by bovine liver mitochondria
Lineweaver-Burk plot of the activity of K I C  dehydrogenase of 
bovine liver mitochondria as a function of substrate ( K I C )  
concentration (v^, nanomoles of CC^ produced per minute per mg of 
protein). Each reaction mixture contained 0.1 ml of a washed 
preparation of mitochondria and the indicated quantities of 
1-^C-KIC (3500 cpm per jjmole) . All other experimental conditions, 
reaction components and assay procedures were as stated for Figure 20.





Fig, 23. —  Effect of varied o-ketoglutarate concentration 
on the rate of formation of CO^ by bovine liver mitochondria
Lineweaver-Burk and Michaelis-Menten plots of the activity of CL-
ketoglutarate dehydrogenase of bovine liver mitochondria as a
function of substrate (KG) concentration (v^, nanomoles of CO^
produced per minute per mg of protein). Each reaction mixture
contained 0.05 ml of a washed preparation of mitochondria and the
II4indicated quantities of 1- C-KG (50,000 cpm per pmole). Reactions 
were allowed to proceed for 10 minutes at 30°C. All other 
experimental conditions, reaction components and assay procedures
were as stated for Figure 20.

85
or the offects of a translocase at the inner membrane, since this
phenomenon was also observed when washed preparations of rat liver
mitochondria served as the source of enzyme, but was not evident
with the purified KG dehydrogenase from pig heart muscle. A Km
value of 0.08 mM KG was calculated from the data illustrated in
Figure 23* The inverse plots shown in Figure 2k allow a K valuem
of 0.22 mM for pyruvate to be computed. The apparent K valuesm
obtained from the average of several determinations are summarized 
in Table U. Inhibition by KIC concentrations in excess of 2.0 mM 
was noted, while no substrate inhibition of the decarboxylase 
activity by concentrations of KIV to 10 mM was found. None of the 
other a-keto acids exhibited this characteristic (substrate 
inhibition) within the ranges of concentration utilized for these 
studies. The true Michaelis constants can not be determined easily 
for these reactions by the methods of Florini and Vestling (70), 
since at least three substrates (NAD', CoA, a-keto acid), and 
perhaps additional cofactors, participate in the tightly coupled 
enzyme reaction sequences of the a-keto acid dehydrogenase complexes. 
Subcellular Distribution of Bovine Liver Branched-Chain 
a-Keto Acid Dehydrogenase Activities 
Among the principal objectives of this entire study was the 
elucidation of the cellular localization of the branched-chain 
keto acid dehydrogenase activities. This was desirable for at 
least two reasons, first to obtain the highest specific enzyme 
activity fraction for the succeeding studies, and second, to 
accumulate additional information with respect to the number of
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TABL , 4
K VALUES FOR SEVERAL a-KETO ACID DEHYDROGENASES OFm
BOVINE LIVER MITOCHONDRIA
a,CC-Keto Acid Substrate K (moles liter 1) m
a - K e  t o i s o v a l e r a t e ------------
a - K e t o i s o c a p r o a t e - - -------
a - K e t o - p - m e t h y l v a l e r a t e
Pyruvate---- ---- - —
a - K e t o g i u t a r a t e --------- -—
3.3 ± 0.4 
5.2 ± 0.6 
4.7 ± 0.8




i o "11 (4)
lo"^ (5)
10_i| (4)
a 14Carboxyl-labeled C-QJ-keto acids were used as substrates for the 
measurement of the enzyme activities by the -^CO evolution assay 
as described in the text and in the Methods section.
j_
Kjh values tabulated are the mean ± one standard deviation for the 
number of determinations indicated in parentheses.
Each reaction mixture contained the following in pmoles: 
mannitol, 150; potassium phosphate buffer, pH 7*2, 33s NAD, 1.0; 
Li3CoA, 0.6 ; Mgci2, 1.0; CaCl2, 1.0; Na2C03, 1.0; 0.05 or 0.1 
ml of a washed preparation of bovine liver mitochondria, and 
appropriate amounts of carboxyl-labeled a-keto acids. 
Determinations were conducted at 30°C.
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Fig. 2k. -- Effect of varied pyruvate concentration on the 
rate of formation of CO^ by bovine liver mitochondria
Lineweaver-Burk plot of the activity of pyruvate dehydrogenase of 
bovine liver mitochondria as a function of pyruvate concentration 
(v^, nanomoles CO^ produced per minute per mg of protein). Each 
reaction mixture contained 0.05 rob of a washed preparation of
lUmitochondria and the indicated amounts of 1- C-Pyr (58,000 cpm per 
pinole). Reactions were allowed to proceed for 10 minutes at 30°C* 
All other experimental conditions, reaction components, and assay 
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branehed-chain keto acid dehydrogenase enzymes in the bovine liver
cell. Figure 25 gives a general indication of the relative levels
of KIC dehydrogenase activity in various bovine liver tissue
preparations obtained by the centrifugation techniques described
in the "Metnods" section. Table 5 shows the distribution of each
branched-chain a-keto acid dehydrogenase activity in these
subcellular fractions. Succinate dehydrogenase (EC 1.3*99»1») was
employed as a mitochondrial marker enzyme (kty), and glucose-6-
phosphatase (EC 3*1»3»9-) served to identify the microsome fraction
(pi). The major portion of the a-keto acid dehydrogenase activity 
llj.at measured by COj production from carboxyl-labeled substrates 
was found in the fraction which contained the mitochondria. The 
origin of the smaller amounts of activity located in the supernatant 
(soluble) fraction is in doubt, since some of the characteristics 
of: this activity appear to differ from those of the mitochondrial 
branched-chain a-keto acid dehydrogenase. The ratios of activity 
with KIV, KMY and KIC are different, and dissimilar coenzyme 
requirements were noted (see Table 2). These distinctive features 
will receive further comment in the "Discussion". Minor amounts of 
activity observed in the nuclear ana microsome fractions likely 
result from some slight contamination with mitochondria.
Localization of q-Keto Acid Dehydrogenase Activities with 
Respect to the Mitochondrial Inner Membrane 
Knowledge of the intra-mitochondrial location of the enzymes 
responsible for the catalysis of oxidative decarboxylation of KIC,
KMV, KIV, pyruvate and a-ketoglutarate in bovine liver cells is of 
considerable general interest, and could contribute to an understanding
TABLE 5

































Nuclear--------- 8.0 0.24 6. l 0.16 9.3 0.21 8.7 0.56
*N.D. N.D.
Mitochondria--- 88.2 5-54 86.8 2.98 88.7 3.51 84.6 3.60 0 .7 2 0.002 \
2.1 0.05 0.8 0.02 0.9 0.02 0.18 83.2 0.2125*3
Soluble--------- 1-7 0 .0 6 2.k 0 .1 7 3.2 0 . % 1.8 0.0 6 N.D. N.D.
%  recovery 95.3 98.9 99-3 100.4 N.D.
N.D. = not determined
Subcellular fractions were prepared as described in the Methods section.
h) )̂jCC-Keto acid dehydrogenase activities were measured with the COp (NAD, CoA) assay (see Methods). 
Succinate dehydrogenase activity was determined by the method of Bonner (49) > and glucose-6-phosphatase 
by the modified method of Nordlie and Arion (51) (see also Methods).
Q
Per cent homogenate refers to the amount of activity present in a fraction compared to the total activity 
for that substrate in the whole homogenate.
dDigitonin solubilization treatment (57) (see also Methods) followed by assays for branched-chain a-keto 
dehydrogenase established the inner membrane-matrix as the location for these enzyme activities.
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Fig. 25. Comparison of relative specific 
dehydrogenase in various bovine liver subcellular
activity of KIC 
fractions
Ik IkThe amounts of CO^ produced from 1- C-KIC during incubation with
varying amounts of the indicated subcellular fractions of bovine
Ikliver was measured by the C02 assay as described in the Methods 
section. The fractions were prepared as stated in Methods.
Each reaction mixture contained in a final volume of 1.0 ml, the 
following (in micromoles): mannitol, 150; potassium phosphate buffer, 
pH 7.2, 33; NAD+, 1.0; Li^CoA, 0.6, MgCl2, 1.0; CaCl2, 1.0; N a ^ O ^  1.0; 
the indicated amounts of enzyme preparation, and 2.0 micromole of 
l-^C-KIC (3700 cpm Per micromole). All reactions were allowed to 




of the relationships among these metabolites. Information about the 
spatial arrangement of these enzymes with respect to the inner 
membrane would provide some clarification of the question of whether 
the a-keto acid substrates must penetrate to the matrix prior to 
oxidation (see footnote d on Table 5)* It is generally accepted 
that the outer membrane of isolated mitochondria is freely 
permeable to substances of low molecular weight (7l,72,73>7*+) > in 
contrast to the apparent selective permeability toward small 
molecules and charged ions characteristically exhibited by the 
inner membrane (50,52,75)* Nucleotide derivatives such as NAD+ 
(52,71), CoA (76) and most substrates which permeate the intra- 
membranal space (10,7 +̂) do not readily penetrate the inner membrane. 
Klingenberg (50) and Mitchell (75) have provided direct evidence 
that the artificial electron acceptor ferricyanide does not 
penetrate the intact inner membrane. This agent has subsequently 
been used by several investigators to determine whether an enzyme 
which can reduce ferricyanide in the presence of its substrate(s) 
is located on the outer side or on the matrix side of the inner 
membrane (see "Methods" for a further discussion of this technique). 
A major site of ferricyanide reduction by mitochondrial preparations 
is at cytochrome c (50). Antimycin A, an inhibitor of respiration, 
is known to block electron transport between reductants inside the 
mitochondria through ubiquinone and cytochrome c to the non­
penetrant ferricyanide which acts as electron acceptor (52). The 
"ferricyanide method" of enzyme localization is therefore based 
upon the inability of ferricyanide to react directly with those
enzymes facing coward the matrix or located in the matrical mileu. 
The relative ability of a substrate to reduce ferricyanide in the 
presence or absence of antimycin A will thus provide information 
pertaining to the intra-organelle location of the enzyme active 
site. The compartmentation of several intramitochondrial enzymes 
has been determined with this technique, among which are the a- 
glycerophosphate dehydrogenase of rat liver and locust flight 
muscle mitochondria (50) and the NADH dehydrogenase of yeast 
mitochondria (7 1). Figure 26 contains representations of actual 
spectrophotometer recordings of the rate of reduction of 
ferricyanide, as measured by the changes in absorbancy at 1+20 nm 
in the presence of a number of substrates. The results in this 
figure and in Table 6 show that antimycin A considerably decreases 
the transfer of electrons to ferricyanide cytochrome c with 
succinate or a-ketoglutarate as substrate, and has some inhibitory 
effect upon reduction with pyruvate. Antimycin A causes 
insignificant diminution of the rate of ferricyanide reduction with 
a-glycerophosphate, KIC, KMV or KIV as the oxidizable substrate.
The results indicate that ferricyanide can apparently interact 
directly with the enzymes catalyzing oxidation of the branched- 
chain a-keto acids, an observation which locates the sites of these 
dehydrogenase activities on the outside of the inner membrane.
Such a situation obviates the need for these compounds to cross the 
inner membrane for oxidation and appears to eliminate the need of a 
specific translocase mechanism for KIC, KIV and KMV. In contrast 
to these activities, the observation that reduction of ferricyanide
95
TABLE 6
SENSITIVITY OF FERRICYANIDE REDUCTION TO ANTIMYCIN A
. . aenzyme activity
Substrate ( s ) ,  mM ______________________________
w/o antimycin + antimycin A per cent
inhibition
a-Glycerol-P 5.7 0.20 + 0.02 0.22 ± 0.01+ 0
Succinate 5.7 0.200 + 0.003 0.006 ± 0.003 70
Pyruvate 5.7 0.100 ± 0.01 o.oi+ ± 0.01 60
Ct-Keto-
glutarate 2.85 0.065 ± 0.01 0.010 ± 0.005 86
a-Ketoiso-
caproate 7-1 0.03 ± 0.01 0.03 ± 0.01 0
a-Keto-p-
methyl-
valerate 5.7 0.05 ± 0.01 0.05 ± 0.01 0
a-Ketoiso-
valerate 7.1 0.05 ± 0.01 0.01+8 ± 0.005 1+
Enzyme activities were estimated by spectrophotometeric 
measurement; of ferricyanide reduction in the presence of substrate, 
at 1+20 nm on a Cary 15 recording spectrophotometer, as described 
in detail in the Methods section. Antimycin A (2 pg/ml) was 
added to assay mixtures where indicated.
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Fig. 26. -- The accessibility of ferricyanide to several a- 
keto acid dehydrogenases compared with its accessibility to succinate 
dehydrogenase and a-glycerol-phosphate dehydrogenase
Spectropnotometric recording of ferricyanide reduction at 1+20 nm 
catalyzed by bovine liver mitochondria with the indicated substrates 
was measured as described in the Methods section. Each reaction 
mixture contained in a final volume of 3*5 ml, the following (in 
micromoles): mannitol, 525; potassium phosphate buffer, pH 7*2, 755
ATP, 3.0; ECTA, 3.5; MgSO^, 10; TPP, 2.5; K3Fe(CN)£, 1.67; 0.1 ml of a 
washed preparation of bovine liver mitochondria, and where indicated, 
succinate, 20 micromoles; a-glycerophosphate, 20 (imoles; KIV, 25 pmoles; 
KMV, 20 pinoles; KIV, 25 pmoles; KG, 10 (mmoles; or pyruvate, 20 micro­
moles. Enzyme activities are calculated as described in the Methods
section.
I min.
in the presence of succinate or a-ketoglutarate is severely 
limited by added antimycin A is in agreement with earlier evidence 
supporting the supposition that the dehydrogenase enzymes for these 
compounds are located on the inside face of the inner membrane or 
in the matrix (77). The observed ability of antimycin A to 
partially inhibit the reduction of ferricyanide by pyruvate implies 
that the pyruvate dehydrogenase complex also faces the inner 
surface of the inner membrane. The results with a-glycerol 
phosphate agree with those obtained by Klingenberg (50), who 
postulated that the mitochondrial a-glycerolphosphate dehydrogenase 
faces the intermembranal space.
The relatively slow rate of penetration of the inner membrane 
by the branched-chain a-keto acids is also inferred indirectly 
from the recordings of the spectrophotometric absorbance of a 
suspension of mitochondria in the presence of high concentration 
of the sodium salt of ehe acid and a permeant cation (e_.£. NH^+) 
as an indicator of osmotic swelling (73)* (See Methods for further 
theoretical and experimental detail). Figure 27 shows that the 
inner membrane of bovine liver mitochondria is apparently less 
permeable to the branched-chain a-keto acids (KIC, KMV. KIV) and 
Ct-glycerolphosphate than toward acetate or inorganic phosphate.
The apparent existence of a permeability barrier to these a-keto 
acids is reminiscent of that previously reported for a-ketoglutarate 
with rat liver mitochondria (77.>78,79)- These data also confirm 
those of Klingenberg (50) for the low rate of permeation of a-GP 




Fig. 27. —  Osmotic response of bovine liver mitochondria to 
l-keto acids and other permeant anions
'urbidity was recorded after addition of mitochondria to an iso- 
'•motic solution of various anions. A decrease of absorption indicates 
iwelling of mitochondria due to the uptake of anions and NH^+ . 
addition of mitochondria (0.5 mg protein per ml) to a mixture of 
:he following (in micromoles): triethanolamine, pH 7*2, 155 
fH^Cl, 755 and KIC, KMV, KIV, a-glycerol-P, sodium phosphate or 
iodium acetate, 7 5 ; in a final volume of 1.5 ml. All reagents were 
idjusted to pH 7*2 and 25°C prior to use. Other experimental conditions 




Investigation into the Number of Branched-Chain q-Keto Acid 
Dehydrogenases In Br .qe Liver Mitochondria 
The ideal approach tu the question of enzyme specificity is to 
isolate the enzyme, which then can be characterized with respect 
to its ability to utilize a variety of substrates. Attempts to 
purify the branched-chain q-keto acid dehydrogenases from 
mammalian liver have been largely unsuccessful (11,13). A 
considerable number of physical and chemical procedures were 
utilized, with generally undesirable effects on the enzyme 
activities (11,13). Connelly, et_ al. (79) have reported a partial 
purification of a semi-specific enzyme from bovine liver supernatant 
fraction which was able to decarboxylate KMV and KICL However, this 
preparation appeared to be unstable to dilution, and thus was 
unsuitable for extensive study.
Dixon and Webb (8l) present a kinetic approach, which can be 
used when the physical separation of two or more enzyme activities 
is not possible, useful for analysis of the question of whether 
one or more dehydrogenases catalyze the oxidative decarboxylation 
of the three branched-chain a-keto acids KIC, KMV and KIV.
According to the relationship shown in Equation 10 (below), if one 
enzyme is involved in a semi-specific conversion of two substrates, 
the observed rate of activity is dependent upon the affinity of 
the enzyme for each of these substrates and thus upon the degree 
of competition between these substrates for the common active center. 
In this case, if A and B are the substrates, the rate of conversion 
of A (v ) in the presence of B can be expressed by the equation;Q.
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(8)
1 + K 1 + -^B-// A  / *b
and the rate of conversion of B (V^) in the presence of A is
expressed by; V, (9).  K,1 + b 1 +/ B / Z a_/K
The total velocity (v ) of the reaction of the enzyme with varying 
amounts of the substrates A and B may be denuted by the sum of 
equations eight and nine.v -  A- / , v, -  B- ,/a — —  + b
v, = v + v, t a b
K, K (10)
1 + / A / ' B /
Ka ^
K& and refer to the respective Michaelis constants for A and B, 
while V 5 and are the maximal vel cities extrapolated at infinite 
substrate concentration. Equation 10 can be expressed in terms of 
the relative concentrations, a = A/Ka, and 3 = B/^, in the 
following manner if the two substrates are being attacked by the 
same enzyme:
\t ( 1 - l  ry ^  j .  \va + a) + vK (1 + p)
vt
1 + a + 3
(11)
This equation is useful to calculate the theoretical total velocity 
(v ) from a knowledge of the initial velocities (v and v ) and the 
K value for each substrate, without having to compute the maximum
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velocity for each instance. The results of a comparison of the
total velocities in the presence of each possible paired combination
of the keto acids, KIV, KIC, KMV, KG and Pyr are presented in Table
7. The specific enzyme activity (v , observed) was determined for
each keto acid separately at two levels of substrate, and with the
indicated substrate combinations. The columns headed v + v,a b
represent the summations of the individual keto acid activities
when present separately in the reaction mixture. This additive
effect would be expected to result from the influence of two separate
enzymes catalyzing the conversion of the two substrates, and no
mutual inhibition. The middle column under each substrate
concentration heading (vt> calculated) gives the values calculated
with the aid of Equation 11. Thus, agreement between the observed
(vfc, observed) and the calculated (v , calculated) total velocities
is considered to be indicative of the participation of a single
enzyme. The only exception to this pattern could occur for two
enzymes E_ and E^, where each is inhibited by the substrate of the
other enzymes, and then only in the incidental case where Kma for E^
is equal to K.- for E, and 1C,, for E, is equivalent to K.-, for E .■*-a b ™b b 1b a
The results of these combined substrate experiments, utilizing
the predetermined K value for each keto acid and initial velocitvm
measurements for the substrates separately and in combination, 
suggest the existence of a single enzyme complex catalyzing the 
oxidative decarboxylation of KIC, KMV and KIV. The data with 
bovine liver mitochondria also indicate that pyruvate and a-keto- 
glutarate dehydrogenase activities are separate from those of the
io4
TABLE 7
RATES OF DECARBOXYLATION OF KIV, KIC, KMV, Pyr AN D  a-KG 
INDIVIDUALLY AND COMBINED51
s p e c i f i c a c t i v i t y
Substrate ( s u b s t r a t e ) ^ ( s u b s t r a t e )
v  v  C v  +  V, t t a  b
o b s e r v e d  c a l c u l a t e d
V  +  V,a  b
o b s e r v e d  c a l c u l a t e d
KIV 4.38 5.55
KIC 3.08 M 9
KMV 3.57 4.66
KG 0.88 1 .9 6
Pyr 2.43 4 .0 1
KIV + KIC 5.26
KIV + KMV 5.32
KIC + KMV 4.03
KIC + Pyr 4.86
KIV + Pyr 6.21




4.90 6 .6 5
3.87 5.51
4 .6 9 6.21
4.20 6.00











1 0 .2 1  
9.05 
8 .4 o  
9.56
8 .6 7
7 . 5 1
KIC + KC 6.35
105












v + vL a b
KMV + KG i+.39 3.19 k.k$ 6.13 k.23 6.62
KG + Pyr 3.17 2.39 3.31 5.^9 3.86 5.97
a-Ketp acid dehydrogenase activities were measured by quantitation of 
the ^C02 produced from carboxyl-labeled a-keto acids in the presence 
of NAD and CoA (see Methods for assay). Each assay mixture contained 
the following, in |umoles: mannitol, 150; potassium phosphate buffer, 
pH 7 .2, 33; NAD, 1.0; Li_CoA, 0.6; MgClp, 1.0; CaCl2, 1.0; Na COo,
1.0; 0.05 or 0 .1 ml of a^washed preparation of bovine liver 
mitochondria, and the indicated quantities of carboxyl-labeled a- 
keto acids adjusted to equivalent specific activities, in a final 
volume of 1.0 ml. All incubations were conducted at 30°C.
Two combinations of a-keto acid concentrations were used. (substrate)^ 
values for each keto acid, in nmoles; KIV, 0.25; KIC, 0.25; KMV,
0.25; KG, 0.05; Pyr, 0.10. (substrate) 2 values, in jjmoles: KIV,
0.50; KIC, 0.50; KMV, 0.50; KG, 0.10; Pyr, 0.30.
Competitive interaction among substrates was assumed for these 
calculations. This assumption is only partially correct for those 
combinations in which a-ketoglutarate and a branched-chain a-keto 
acids were paired.
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branched-chaia keto kcid dehydrogenase, which is consistent with 
the specificity studies on the purified pyruvate and a-ketoglutarate 
dehydrogenase complexes from pig heart (38j63)., E. coli (64) and 
bovine kidney mitochondria (82).
The assumption of a single dehydrogenase with equal affinities 
for each substrate^- predicts that "cold" (non-radioactive) keto 
acid (inhibitor) in equal concentration with labeled a-keto acid 
(substrate) will result in 50 per cent observed inhibition, based
14 14upon measurement of CC^ evolved. Production of CO^ will be 
inhibited to the extent of seventy-five per cent when the ratio of 
"cold" to radioactive keto acid is three to one. Each of the 
branched-chain a-keto acids inhibited the jLn vitro oxidation of 
the other two acids (Table 8). The pattern of these inhibitory 
effects approximates the general hypothesis of one catalytic site 
for all pairs of the branched-chain a-keto acids. The rate of 
oxidation of pyruvate was substantially reduced by a-ketobutyrate, 
a compound which also inhibited decarboxylation of the branched-chain 
acids, but to a lesser degree. a-Ketocaproate and a-ketovalerate, 
straight chain analogues of the branched-chain keto acids, KIC and
14K I V ,  were able to inhibit significantly the CO^ production from 
the carboxyl-labeled keto acids. A  more extensive and quantitative 
study of mutual inhibition patterns is presented in a later section.
Parallel responses to various physical perturbing techniques
is sometimes used as supporting evidence for the existence of a
single enzyme, while differential effects of identical treatment
^Michaelis constants were similar, but not identical for KIC,
KMV and KIV (see Table 4).
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INHIBITION OF a-KETO ACID DEHYDROGENASES BY a-KETO ACIDS3
TABLE 8
I n h i b i t o r a r b o x y l - “ ^ C - l a b e l e d  a - k e t o  a c i d ,  (S) =  1 mM
KIV KIC KMV KG Pyr




1.0 mM-------  5 6
3.0 mM-------  78
12C-Ct-Keto-(3-methy 1- 
valerate
1.0 mM.... ... 52
3.0 mM-------  79
12„G-a-Ketobutyrate
1.0 mM-------  29
3.0 mM--- ----
12C-a-Ketocaproate
1.0 mM-------  66
3.0 mM-------
12C-a-Ketovalerate
1.0 mM.......  67
3.0 mM..... —  92
°j0 inhibition
kk 54 2k 33









3,a-Keto acid dehydrogenase activities were measured by quantitation 
of the ^ C 02 produced when ■‘-^-carboxyl-labeled a-keto acids were 
incubated at 30 C with washed preparations of bovine liver 
mitochondria. 1-^C-a-keto adds were used as inhibitors. Each 
reaction mixture contained, in a final volume of 1.0 ml, in 
(jmo 1 es: mannitol, 150; potassium phosphate buffer, pH 7*2, 33>N AD, 1.0; L i ^ C o A ,  0.6; MgClo, 1.0; CaClg, 1.0; NagCÔ ., 1.0; 0.05 ml o f  e n z y m e  p r e p a r a t i o n  a n d  t n e  i n d i c a t e d  a m o u n t s  o r  a - k e t o  a c i d  s u b s t r a t e  a n d  i n h i b i t o r .
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upon two activities may indicate separate enzymes. Figure 28 
illustrates the nearly parallel pattern of variation of the branched- 
chain cc-keto acid dehydrogenase activities during storage of isolated 
mitochondria at 1*°C. All three activities (KIC, KMV, KIV) increased 
during the first 2b hours, followed by a gradual decrease in the 
succeeding 72 hours. The slightly different response of KIV 
dehydrogenase activity as compared to KMV and KIC activities, could 
be a result of experimental variance, or may suggest the possibility 
of multiple enzymes. a-Ketoglutarate dehydrogenase activity, 
measured concurrently, did not vary significantly over the entire 
96 hour interval.
The data of Figure 29 show that KIC dehydrogenase and pyruvate 
dehydrogenase respond differently to preincubation of isolated 
mitochondria for varied time intervals at 1+5°C. KIC dehydrogenase 
activity appears to increase, relative to the initial measurement, 
subsequent to a short exposure to the b^°C temperature. Longer 
periods of incubation at this temperature resulted in rapid 
inactivation of KIC dehydrogenase, while pyruvate dehydrogenase 
activity showed a steady decrease for all incubation intervals. The 
response of KMV and KIV dehydrogenase activities closely mimics 
that observed for KIC. Danner (83) had previously noted a similar 
response with KIC dehydrogenase of rat liver mitochondria.
When washed preparations of bovine liver mitochondria were 
incubated with various concentrations of sodium arsenite the 
branched-chain a-keto acid dehydrogenase activities declined at 
nearly identical rates (Figure 30)* Since arsenite is known to form
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Fig. 28. —  Effect of incubation at i+°G on a-keto acid 
dehydrogenase activities
Bovine liver mitochondria (25 mg/ml) were stored at 4°C for the 
indicated time periods. The mitochondria were prepared as described 
in the Methods. G-Keto acid dehydrogenase activities were measured 
by the ferricyanide reduction assay (see Methods section for 
procedure) at each of the stated time periods. One-tenth ml of 
mitochondria was used for each determination. Activity (in micro­




















Ft 29, Inactivation of a-keto acid dehydrogenases with
time of '...cuoai ion at i+5°C
Washed liver nitochondria were suspended in 0.30 M mannitol at a
concentration n c 23 mg of protein per ml. The suspension was
incubated in a 45°c bath and 0.1 ml samples withdrawn and assayed
immediately for dehydrogenase activity with KIC ( 0 - 0  ) and Pyr
(see text or Methods for details). Zero time assays and
blanks were in triplicate, other points in duplicate. Activities are
expressed as percentage of activity in samples not incubated at ^5°C. 
li+The C0o assay method was utilized. Each reaction mixture contained 
the following in a final volume of 1.0 ml (in |umoles) mannitol, 150; 
potassium phosphate buffer, pH rJ.2, 33> NAD, 1.0; Li^CoA, 0.6; MgC^, 
1.0; CaCl2, 1.0; Na^CO^j 1.0; and either l-li+OKIC (3700 cpm per pmole), 
















Fig. 30. -- Inhibition of branched-chain a-keto acid 
oxidative decarboxylation by arsenite
Plots of per cent of original activity (in absence of arsenite) vs. 
arsenite concentration. A diluted suspension of fresh mitochondria 
(1.25 mg prctein/ml of suspension) was incubated for 10 minutes at 
25°C in the presence of the indicated concentration of sodium 
arsenite, JJranched-chain a-keto acid dehydrogenase activity was
lUmeasured bj the CO^ assay as described in the Methods section.
Each reaction mixture contained 0.1 ml of the treated or the untreated 
mitochondr ial suspension and 2.0 |j.moles of l-'*' Oketo acid; ( KMV), 
!§|, KIC,!, (iHi, KIV). Reactions were allowed to proceed for 10 
minutes at 30°C. All other components of the basic reaction mixture 
were the same as for Figure 28.




mercaptides with thiol groups, these data imply the presence of a 
sulfhydryl group (or groups) functional in the oxidative 
decarboxylation of the branched-chain a-keto acids. A logical 
suggestion, in view of the proposed similarity of the oxidative 
pathways of these keto acids to those for pyruvate and a-keto- 
glutarate, would be that the observed inhibition by arsenite occurs 
through oxidation 01 the dithiol of reduced lipoic acid.
Mutual Inhibition In Vitro Among a-Keto Acid Substrates
A thorough investigation of the relative inhibitory interactions 
among several a-keto acids, including the branched-chain acids KIV,
KIC and KMV, was initiated. Two major objectives were first to 
determine whether these interrelationships could constitute a 
possible physiological regulatory mechanism among the keto acids 
under conditions of "normal" a-keto acid levels in mammalian tissues, 
and second, to ascertain to what extent the in vitro metabolism of 
a-ketoglutarate and pyruvate is affected by the levels of KIV, KIC 
and KMV reported to occur in untreated branched-chain ketoaciduria,
a-Keto acid dehydrogenase activity was estimated by measurement
II4.of the amounts of radioactive CC^ evolved from carboxyl-labeled 
a-keto acids as described under Methods. Non-radioactive a-keto 
acid was utilized as the inhibitor in each of the studies. Variation 
of substrate concentration at each of several inhibitor concentrations 
generated the values for the double reciprocal plots shown in 
Figures 31 and 32, which illustrate the apparent competitive nature 
of the inhibition by KMV and KIV of KIC oxidation. Reciprocal 
plots in Figures 33 and 3 +̂ illustrate that the oxidative
Fig. 31. —  Lineweaver-Burk plots of the inhibition of a- 
ketoisocaproate dehydrogenase activity by a-keto-P methylvalerate
12 lliLineweaver-Burk plots with 1- C-KMV as inhibitor and 1- C-KIC as 
varied substrate. ( 0  £  ) no inhibitor, ( J|--------- |§§ )
2.5 x 10_^M KMV, ( 4k------Ĵ ) 5 x 10~Si KMV, ( O -------- O )
-k7.5 x 10 M KMV. KIC dehydrogenase activity was measured by the 
ll).CO^ assay as described in the following (in famoles): mannitol,
150; potassium phosphate buffer, pH 7.2, 335 NAD, 1.0; Li^CoA, 0.6;
lUMgCl^, 1.0; CaCl̂ , 1.0; Na^CO^., 1.0; the indicated amounts of 1- C- 
KXC (3500 cpm per pinole) and inhibitor, and 0.1 ml of a washed 
preparation of bovine liver mitochondria in a final volume of 1.0 ml. 
All reactions were allowed to proceed for 10 minutes at 30°C. (v\,
nanomoles CO^ per minute per mg of protein).
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Fig. 32. —  Lineweaver-Burk plots of the inhibition of a -  
ketoisocaproate dehydrogenase activity by a-ketoisovalerate
12 IkLineweaver-Burk plots with 1- C-KIV as inhibitor and 1- C-KIC as
varied substrate. ( &  --- ) no inhibitor, ( 0 ----------0 )
-k -k2.5 x 10 M KIV, ( A ------- A  ) 5 x 10 M KIV, ( O ------- O )
-k7.5 x 10 M KIV, Each reaction mixture contained 0.1 ml of a washed
preparation of bovine liver mitochondria, and the indicated amounts 
of 1-^C-KIC (3600 cpm per |omole) and inhibitor. All other 
experimental conditions, reaction mixture components and assay 
methods were as stated for Figure 31. (v^, nanomoles CO^ produced
per minute per mg of protein).
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Fig. 33* Lineweaver-Burk plots of the inhibition of a- 
ketoisovalerate dehydrogenase activity by a-ketoisocaproate
12 1^Lineweaver-Burk plots with 1- C-KIC as inhibitor and 1- C-KIV as 
varied substrate. ---— —® )  no inhibitor, ( ( -- ------1§§ )
2.5 x 10 Si KIC, ( A — --- A  ) 5.0 x 10 Si Kic, ( Q-----— O  }
-b7.5 x 10 M KIC. Each reaction mixture contained 0.1 ml of a washed
preparation of bovine liver mitochondria and the indicated amounts 
of 1-^C-KIV (3500 cpm per pinole) and inhibitor. All other 
experimental conditions, reaction mixture components and assay 
methods were as stated for Figure 31* (v^, nanomoles of C0^
produced per minute per mg of protein).
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Fig. 3b. —  Lineweaver-Burk plots of the inhibition of a- 
ketoisovalerate dehydrogenase activity by a-keto-3-methylvalerate
12 lbLineweaver-Burk plots with 1- C-KMV as inhibitor and 1- C-KIV
as varied substrate. ( f) ) no inhibitor, (f|-- ----- )
-b . - o5 x 10 M KMV, ( jfa--------1.0 x 10 'T-l KMV. Each reaction
mixture contained 0.1 ml of a washed preparation of bovine liver
lbmitochondria and the indicated amounts of 1- C-KIV (3500 cpm per 
pmole) and inhibitor. All other experimental conditions, reaction 
mixture components and assay methods were as described in Figure 31*
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decarboxylation of K I V  is inhibited competitively by either KMV
lUor KIC in this system. Production of CO^ from carboxyl-labeled 
KMV is also subject to competitive inhibition by Kid or KIV as 
seen in the Lineweaver-Burk plots of Figures 35 and 36. Thus, 
each of the branched-chain a-keto acids is able to compete for 
the oxidative process in the mitochondrial system.
The rate of in vitro oxidative decarboxylation of pyruvate 
by bovine liver mitochondria was decreased significantly in the 
presence of the branched-chain keto acids. Figure 37 indicates, 
in double reciprocal form, that KIC acts as a competitive 
inhibitor of pyruvate oxidation. The Dixon plots (84) of Figure 38 
disclose a similar competitive effect for KIV upon the utilization 
of pyruvate by bovine liver mitochondria. The Dixon plots of 
Figure 39 illustrate the competitive inhibition of pyruvate 
oxidative decarboxylation by KMV.
The catabolism of a-ketoglutarate was inhibited by K I C  
(Figure 40), KMV (Figure 4l) , and K I V  (Figure 42). The apparent 
•nixed type of inhibition was noted with each of the branched-chain 
a-keto acids. These findings agree with those previously obtained 
for the purified a-ketoglutarate dehydrogenase complex from pig 
heart mitochondria (38).
The influence of a-ketocaproate (KC), a straight-chain
14analogue of KIC and KMV, on the production of CO  ̂from carboxyl-
labeled KIC or KIV was also examined. It was assumed that KC 
would act as a competitive inhibitor of the oxidation of these two 
branched-chain keto acids, and could thus be used as an agent for
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Fig- 35* —  Lineweaver-Burk plots of the inhibition of a- 
keto-f3-met:hylvalerate dehydrogenase activity by a-ketoisocaproate
12Lineweaver-Burk plots with 1- C-KIC as inhibitor and carboxyl-
labeled KFV as varied substrate. ( ----) no inhibitor,
( S - ------------ H  ) 2.5 X  Icf^M KIC, ( ------- ^  ) 7.5 x  10_^M KIC.
Each reaccion mixture contained 0.1 ml of a washed preparation
of bovine liver mitochondria and the indicated amounts of labeled
KMV (2050 cpm per |umole) and inhibitor. All other experimental
conditions, reaction media and assay methods were as stated for









Fig. 36. -- Lineweaver-Burk plots of the inhibition of a-keto' 
8-methylvalerate dehydrogenase activity by a-ketoisocaproate
12Lineweaver-Burk plots with 1- C-KIC as inhibitor and carboxyl-
labeled KIP/ as varied substrate. ( —— —  ) no inhibitor,
( i § ~ ----- -41) 2.5 x lCfSl KIC, ( £ ------ ) 5-0 x 10~Sl KIC,
{ Q ----- --— O  ) 7-5 x 10 Su KIC. Each reaction mixture contained
0.1 ml of a washed preparation of bovine liver mitochondria, 
the indicated amount of labeled KMV (2050 cpm per pinole) and 
inhibitor. All other experimental conditions, reaction media and 
assay methods were as stated for Figure 3!. (v^, nanom°les CO^





Fig* 37* —  Lineweaver-Burk plots of the inhibition of 
>yruvate dehydrogenase activity by a-ketoisocaproate
IP T V.jineweaver-Burk plots with 1- C-KIC as inhibitor and l-xl+C-pyruvate 
is varied substrate. (0 ---- — $  ) no inhibitor, ( g§-— )
2.5 x 10"\l 1-12C-KIC, (At— — A)  7-5 x i o^ m  i- 12c -k i c ,
O --- — --O )  1.0 X 10"3M 1-12C-KIC, ( Q - ------Q )  2.0 x 10""Si
12C-KIC. Pyruvate dehydrogenase activity was measured by the
bC0o assay as described in the Methods section. Each reaction
fixture contained in a final volume of 1.0 ml, the following (in
licromoles), mannitol, 150; potassium phosphate buffer, pH 1.2, 335
iAD, 1.0; Li^CoA, 0.6; MgCl2, 1.0; CaClg, 1.0; Na2C03, 1.0; 0.05 ml
>f a washed preparation of bovine liver mitochondria (1 .3 mg protein)
lbmd the indicated amounts of 1- C-pyruvate and inhibitor. The 
•eactions were allowed to proceed for 10 min at 30°C. (v , nanomoles 
:02 produced per minute per mg protein).
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Fig. 38. —  Dixon plot of the inhibition of pyruvate 
dehydrogenase activity by a-ketoisovalerate
12 ll+Dixon plot with 1- C-KIV as varied inhibitor and 1- C-pyruvate
as substrate, ( # ------) 1.0 x 10 l-^C-pyr ( §§■— — ..... '-fH )
—14. 143.0 x 10 M l -  C-pyr. Each reaction mixture contained 0.05 nil of
a washed preparation of bovine liver mitochondria, the indicated
14amounts of 1- C-pyr (58,500 cpm Per pmole) and quantities of 
inhibitor as noted in the figure. All other experimental 
conditions, reaction media and assay methods were as stated for 




Fig* 39* —  Dixon plot of the inhibition of pyruvate 
dehydrogenase activity by a-keto-{3-methy lvalerate
12 lUDixon plot with 1- C-KMV as varied inhibitor and 1- C-pyruvate
as substrate. (||---  III) 5 x 10 1-^C-pyr, ( £ ------- )
- k  lit1.5 x 10 M i- C-pyr. Each reaction mixture contained 0.05 nil 
of a washed preparation of bovine liver mitochondria with the 
indicated amounts of 1- C-pyr (58,500 cpm per pinole) and inhibitor. 
All other experimental conditions, reaction media and assay methods 
were as stated for Figure 37* (v^, nanomoles of CO^ produced per




F i g .  40. —  L i n e w e a v e r - B u r k  p l o t s  o f  t h e  i n h i b i t i o n  o f  Qf- 
k e t o g l u t _ r a t e  d e h y d r o g e n a s e  a c t i v i t y  b y  a - k e t o i s o c a p r o a t e
12 14Lineweaver-Burk plots with 1- C-KIC as inhibitor and 1- C- 
a-ketoglutarate as the varied substrate. ((@—  £  ) no
inhibitor, ( |§~ — |g ) 5 x lo’^M KIC, ( Jfe-— --A )  1-5 x lo”^M
K I C .  a - K e t o g l u t a r a t e  d e h y d r o g e n a s e  a c t i v i t y  w a s  m e a s u r e d  b y  t h e
*| |
C0? assay as described in the Methods section (v^, nanomoles CO2 
produced per minute per mg protein). Each reaction mixture contained 
in a final volume of 1.0 ml, the following (in micromoles), mannitol, 
150; potassium phosphate buffer, pH "J.2, 335 NAD, 1.0; Li^CoA, 0.6; 
MgCl2, 1,0; CaCl^j 1.0; Na^CO^, 1.0; 0.05 ml of a washed preparation 
of bovine liver mitochondria (1 .3 nig protein), and the indicated
14 , \ ,a m o u n t s  o f  1- C - a - k e t o g l u t a r a t e  (50,000 cp m  p e r  j j j n o l e )  a n d  




x io 3m  1
.̂ 6
137
Fig. 4l. -- Lineweaver-Burk plots of the inhibition of a- 
ketoglutarate dehydrogenase activity by a-keto-^-methylvalerate
12 14Lineweaver-Burk plots with 1- C-KMV as inhibitor and 1- C-KG as
the varied substrate. ( # -------- - # )  no inhibitor, ( Q —-- - --)
5.0 x lo’Sl KMV, ( A -------A )  1-5 x 10~\ KMV. Each reaction
mixture contained 0.05 tnl of a washed preparation of bovine liver
14 ,mitochondria with the indicated amounts of 1- C-KG (50,000 cpm per 
umole), and inhibitor. All other experimental conditions, reaction 
media and assay methods were as stated for Figure 40. (v , 
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Fig. k2, —  Lineaver-Burk plots of the inhibition of a- 
etoglutarate dehydrogenase activity by a-ketoisovalerate
12 1Uineweaver-Burk plots with 1- C-KIV as inhibitor and 1- "C-KG as
aried substrate. (#--------0  ) no inhibitor, ( 0 — -----0  )
.0 x 10"Si KIV, ( A —  ~ A )  1.0 x 10"3M KIV, ( O — ----- O )
.0 x 10 Si KIV. Each reaction contained 0.0p nil of a washed 
reparation of bovine liver mitochondria with the indicated amount 
f l-^+O K G  (50,000 cpm per jjmole) and inhibitor. All other 
xperimental conditions, reaction media and assay methods were as 




further investigation of the number of enzymes involved in the
oxidation of KIC and KIV, since if only one enzyme is concerned,
a competitive inhibitor should give the same value of K. when
x
tested with either substrate. While KC did in fact inhibit the 
dehydrogenase activity with either KIC (Figure 1+3) or KIV 
(Figure 1+1+), the inhibition appeared to be of a mixed nature.
Though the values were calculated (2.1+ x 10 Si and 1+.8 x 10 Si), 
their value as a diagnostic tool is definitely lessened by the 
suggestion that KC may be interacting with the enzyme(s) at 
other than the catalytic site since the inhibition observed 
appeared to be of a mixed type. Oxidation of KIV is also inhibited 
by its straight-chain analogue, a-ketovalerate (KV), as evidenced 
by the data shown in the Dixon plots of Figure 1+5. The 
observation that the values of for the straight-chain keto 
acids KC and KV are somewhat lower (see Table Q) than are the K 
values for the branched-chain analogues KIC and KIV may indicate 
preference of the enzyme for the unbranched compounds. This 
findings is of only incidental interest at present, since the 
physiological function or occurrence of KC and KV have not been 
investigated in mammalian tissues. On the other hand, a-keto- 
butyrate (KB), an a-keto acid of considerable importance in the 
catabolic pathways of methionine and threonine, has been reported 
to accumulate in the plasma of branched-chain ketoaciduric 
patients (16). Recent investigation has shown that KB is 
oxidized to propionyl-CoA by the pyruvate dehydrogenase complex 
(38) at a substantial rate. The oxidation of KIC (Figure 1+6)
TABLE 9















121- C-KMV..... 8 ,6  x 10 il 2.5 x I0~h 2 .3  x l o ” 3 l.k x 10~3
121- C-KIC... — 6.9 x 10“)+ 1.3 x 10 1 -k5.1* X 10 2,k x  l o ’ 3
i-12c -kiv..... 2.2 x 10"if -h1.95 x 10 uk X  10~3 8 .2  x 10 +
121- C-KV..... - -1+0.5 x 10
i-12c -rc------ 2.2 x 10 4 U .8 x 10'1*
121-1 T-KB...... 1 .1 x lo” 3 k.l x 10 ^
a ll|a-Keto acid dehydrogenase activities were measured by quantitation of CO^ produced from
carboxyl-labeled a-keto acids.
Reaction conditions and assay methods are described in the legends to Figures 31-l+Y and in the
Methods. Each K. value tabulated represents the average of at least three determinations.i
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fig* 43. ”  Lineweaver-Burk plots of the inhibition of 
a-ketoisocaproate dehydrogenase activity by a-ketocaproate (KC)
12 lkLmeweaver-Burk plots with 1- C-a-KC as inhibitor and 1- C-
KIC as the varied substrate. ^ ) no inhibitor,
H I — -- -— H I ) 5*0 x 10 M 1- C-KC. a-Ketoisocaproate
Ikdehydrogenase activity was measured by the CO^ assay as described 
in the Methods section. Each reaction mixture contained in a 
final volume of 1.0 ml, the following (in micromoles), mannitol, 150; 
NAD, 1.0; Li^CoA, 0.6; MgCl2, 1.0; CaCl2, 1.0; Ha^CO^, 1.0; 0.1 ml 
of a washed preparation of bovine liver mitochondria (2.6 mg protein),
lkand the indicated amounts of 1- C-KIC and inhibitor. All reactions 
were allowed to proceed for 20 minutes at 30°C. (v^, nanomoles C02
produced per minute per mg protein).
' !' ; : v ' : ■: '
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Fig, 44, -- Lineweaver-Burk plots of the inhibition of a- 
itoisovalerate dehydrogenase activity by a-ketocaproace
12.neweaver-Burk plots wich 1- C-Q!-ketocaproate (a-KC) as inhibitor
14 , ̂td 1- C-a-KIV as varied substrate, ) no inhibitor,
8- -4.~~— SI) 1.0 x 10 M a-KC. a-Ketoisovalerate dehydrogenase
14tivity was measured by the CO^ assay as described in the 
ithods section (v^ nanomoles CO^ produced per minute per mg of 
otein). Each reaction mixture contained in a final volume of 
0 ml, the following (in micromoles), mannitol. 150; potassium 
osphate buffer, pH 7,2, 33* P-NAD, 1.0; Li CoA, 0.6; MgCl0, 1.0; 
Cl^j 1.0; Na^CO^, 1.0; 0.1 ml of a washed preparation of bovine 
ver mitochondria (2.6 mg protein), and the indicated amounts ox
14C-KIV and inhibitor. All reactions were allowed to proceed for
minutes at 30°C.
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Fig. 1+5. —  Dixon plot of the inhibition of a-ketoisovalerate
dehydrogenase activity by c.-ketovalerate (KV)
Dixon plot with 1- C-KV as the varied inhibitor and 1- C-a-KIV 
as the keto acid substrate. ( # — — — — # )  2.5 c 10~Sl KIV-l-^C,
( H --- --- ■ )  5.0 x lO^M KIV-l-^C, l-li+C-KIV. a-Ke to iso vale rate
114-dehydrogenase activity was measured by the CO^ assay as described
in the Methods section. Each reaction mixture contained in a final
volume of 1.0 ml. the following (in micromoles); mannitol, 150;
potassium phosphate buffer pH 7«2, 335 NAD, 1.0; Li CoA, 0.6; MgCl„,
3
1.0; CaCl^, 1.0; Na^CO,, 1,0; 0.1 ml of a washed preparation of 
bovine liver mitochondria, and the indicated amounts of 1-^C-KIV 
and inhibitor. The react:.ons were allowed to proceed for 10 minutes 
at 30°C. (v^, nanomoles CjQ̂ per minute per mg protein).
s j,. ?  * * * * ZPf** ”
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Fig. 46. -- Lineweaver-Burk plots of .he inhibition of CC- 
ketoisocaproate dehydrogenase activity by a-ketobutyrate (KB)
12 14Lineweaver-Burk plots with 1- C-KB as inhibitor and 1- C-KIC
as varied substrate. ( B ------- no inhibitor, ( ■ ------------B )
0.25 mM KB, ( ▲ -------A) 0.75 mM KB, ( O ------- - o  ) 1.50 ml! KB.
Each reaction mixture contained 0.1 ml of a washed preparation 
of bovine liver mitochondria (2.4 mg of protein) with the indicated 
amounts of 1-^C-KIC (36OO cpm per pinole) and inhibitor. All 
other experimental conditions, reaction media, and assay methods 
were as stated for Figure 43. (v̂ , nanomoles C0  ̂produced per
minute per mg protein).
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and of pyruvate (Figure ^7) was affected deleteriously by low 
levels of KB in vitro.
The results from the inhibition studies illustrated by Figures 
31 to k j  and summarized in Table 9 indicate that the metabolism of 
these keto acids is markedly influenced by the relative levels of 
the various a-kefo acids in the normal liver cell (see Appendix II 
for normal levels of some amino acids and keto acids). From these 
data it is evident that one consequence of increased KIC 
concentrations will be the effective and detrimental influence 
upon the conversion of pyruvate to acetvl-CoA by pyruvate 
dehydrogenase. Further implications of the mutual interactions 
among the a*keto acids KMV. KIC and KIV and the effects of these 
keto acids on the catabolism of a-ketoglutarate and pyruvate with 
reference to the normal metabolism of the liver and with respect 
to the aberrant situation associated with the diseased (branched- 
chain ketoaciduria) state will be considered in the "Discussion".
Fig. I4.7. —  Lineweaver-Burk plots of the inhibition of 
pyruvate dehydrogenase activity by cc-ketobutyrate
12 litbineweaver-Burk plots with 1- C-KB as inhibitor and 1~ 'C-pyruvate
(52,600 cpm per pmole) as the varied substrate. ( ^ — — — — —-^) no
inhibitor, (H “------H  0.25 mM KB, ) 0.75 mM KB.
Each reaction mixture contained 0.05 ml of a washed preparation
of bovine liver mitochondria (1.2 mg of protein) with the indicated
amounts of l-^C-pyr (58,500 cpm per jjinole) and inhibitor.
Reactions were allowed to proceed for i0 minutes at 30°C. All other
experimental conditions, reaction media and assay methods were as




A comprehensive delineation of the intricate regulatory 
mechanisms which modify the catabolism of the branched-chain amino 
acids is only recently emerging from several investigations of 
the catabolic enzymes. The major thrust of initial studies of 
the metabolism of the oranched-chain amino acids centered upon 
the characterization of the overall degradative pathways of leucine, 
isoleucine and valine (l); elucidation of the site of the catabolism 
of these compounds in the genetic disease branched-chain keto- 
aciduria (21,23,24) and development of therapeutic dietary 
treatment designed to control the symptoms of the disease (20,32). 
Recently however, there has been evidenced a growing awareness of 
the complexity and multiplicity of the regulatory mechanisms which 
may function to maintain a fine balance among the cellular levels 
of the branched-chain amino acids and keto acids in the normal 
mammalian system.
A thorough description of the regulation of the metabolism of 
these compounds must integrate such known facts as the variation 
in distribution among tissues of the transaminases and ct-keto acid 
dehydrogenases, differences in the adaptive responses of these 
enzymes to variation in diet or availability of substrates, and the 
number and specificities of these enzymes. Furthermore, of 
considerable importance to such a discussion is the consideration 
of tne mode and extent of any mutual interferences among these154
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reactions. The influence of permeability barriers between substrates 
and enzymes imposed by physical compartmcntation of constituent 
enzymes involved with the catabolic sequence may also contribute 
to the overall control apparatus.
The metabolism of the amino groups of leucine, isoleucine and 
valine appears to be regulated by several factors, including the 
availability of amino group acceptor (l6) and induction of amino­
transferase enzymes (11,85). That the further catabolism of these 
amino acids is subject to genetic control is evident from the 
studies of Wohlheuter and Harper (ll), who have shown a parallel 
increase in the branched-chain a-keto acid dehydrogenase activities 
in response to increased dietary intake of protein. During the 
course of their investigations of this phenomenon, they noted a 
second modulation of the dehydrogenase activities, not affected 
by known inducing agents, which was tentatively identified as a 
pattern of diurnal variation.
A substantial elevation of the plasma levels of the branched-
chain amino acids occurs in animals fed a diet high in prctein.
For example, Anderson ejt al. (86) have reported leucine concentrations- l iof approximately 10 M in the plasma of rats fed a controlled diet 
containing five per cent casein hydrolysate. However, within one 
day after initiation of a force-fed diet which contained 25 per 
cent protein, the levels of leucine increased nearly five-fold. 
Leucine, isoleucine and valine concentrations remained elevated 
for two to three days if the 25 per cent casein diet was continued, 
then decreased gradually to a steady state slightly higher than was
o b s e r v e d  i n i t i a l l y .  M e i s t e r  ( l 4 )  h a s  shown t h a t  t h e  r e l a t i v e  c o n c e n t r a t i o n s  o f  f r e e  b r a n c h e d - c h a i n  am ino a c i d s  a n d  t h e i r  r e s p e c t i v e  a - k e t o  a c i d s  i n  m a m m a lia n  l i v e r  a r e  n e a r l y  e q u i v a l e n t ,  b a s e d  o n  t h e  e q u i l i b r i u m  c o n s t a n t s  f o r  t h e i r  i n t e r c o n v e r s i o n .  T h i s  w o u l d  i n d i c a t e  t h a t  u n d e r  c o n d i t i o n s  o f  a b n o r m a l l y  i n c r e a s e d  l e u c i n e ,  i s o l e u c i n e  a n d  v a l i n e  l e v e l s  t h e  c o n c e n t r a t i o n s  o f  K I C ,  KMV a n d  K I V  
w o u l d  b e  e x p e c t e d  t o  i n c r e a s e  c o n c u r r e n t l y .I n  v i e w  o f  t h e  i m p o r t a n c e  w h i c h  m u s t  be a t t a c h e d  t o  t h e  
d e g r a d a t i v e  p a t h w a y s  f o r  t h e  e s s e n t i a l  am ino a c i d s  l e u c i n e ,  i s o l e u c i n e  a n d  v a l i n e ,  a d i s c u s s i o n  o f  t h e s e  p a t h w a y s  a n d  a c o n s i d e r a t i o n  o f  p o t e n t i a l  r e g u l a t o r y  m e c h a n is m s  i s  i m p o r t a n t  t o  t h e  u n d e r s t a n d i n g  o f  how t h e  m e t a b o l i s m  o f  t h e s e  co m p ou nd s m i g h t  b e  c o n t r o l l e d .  R e c o g n i t i o n  and  q u a n t i t a t i o n  o f  t h e  c h a r a c t e r i s t i c s  o f  t h e  i n d i v i d u a l  e n z y m a t i c  s t e p s  a n d  o f  t h e  i n t e r a c t i o n s  am ong 
t h e s e  m e t a b o l i t e s  i n  t h e  n o r m a l  c o u r s e  o f  m e t a b o l i s m  a l s o  m ay  r e s u l t  i n  a  c l e a r e r  u n d e r s t a n d i n g  o f  t h e  a b e r r a n t  e v e n t s  a s s o c i a t e d  w i t h  b r a n c h e d - c h a i n  k e t o a c i d u r i a .T he o x i d a t i v e  d e c a r b o x y l a t i o n  o f  t h e  b r a n c h e d - c h a i n  a - k e t o  a c i d s ,  t h e  s e c o n d  s t e p  i n  t h e  c a t a b o l i s m  o f  t h e  c o r r e s p o n d i n g  am ino 
a c i d s ,  may be s p e c u l a t e d  t o  be  a  l o g i c a l  c a n d i d a t e  a s  a  s i t e  o f  m e t a b o l i c  r e g u l a t i o n ,  o w n i n g  t o  t h e  c o m p l e x  n a t u r e  o f  t h e  m u l t i e n z y m e  u n i t s  w h ic h  c a t a l y z e  t h i s  c o n v e r s i o n ,  and t o  t h e  e s s e n t i a l l y  i r r e v e r s i b l e  d i v e r s i o n  o f  c a r b o n  aw ay fr o m  t h e  m a i n s t r e a m  o f  am ino a c i d  and o r o t e i n  m e t a b o l i s m .
It has been variously postulated that one, two or even three 
separate enzymes may be responsible for the oxidative decarboxylation
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of KIC, KMV and KIV in mammals. The combined substrate experiments
performed in these studies imply the existence of a single
dehydrogenase, as do the similar responses, jLn vitro, to perturbing
influences such as subjection to mild heating, pH variation, and
arsenite treatment. Mutual inhibition among KIC, KMV and KIV
(Table 8) approximate that which will be expected for competitive
interaction at a single binding site. However, the values for K’ m
and K. which were determined for the branched-chain keto acids arei
sufficiently similar so that the observed pattern could be 
attributed to the influence of multiple dehydrogenases for KMV, KIC 
and KIV. Nevertheless, the weight of evidence from this work appears 
to favor the former hypothesis. Ultimately the acceptance of a one 
enzyme model requires the demonstration of a single homogeneous 
enzyme complex having activity with all three keto acids.
The assumption of a single branched-chain a-keto acid 
dehydrogenase from mitochondria should not he construed as contra­
dictory to the demonstration, by Connelly et al. (27,80), of a 
soluble KIC-KMV dehydrogenase from bovine liver cell preparations. 
This enzyme was partially purified, and by a variety of criteria, 
was considered to be a single enzyme. The subcellulir distribution 
studies reported here indicate that in bovine liver, the 
dehydrogenase activity with KIC, KMV and K I V  is predominantly 
associated with the mitochondria, with roughly ten per cent of the 
total decarboxylase activity with either KMV or KIC occurring in 
the "soluble" (jL.e,. not sedimented at 80,000 x for one hour) 
fraction. Very little KIV decarboxylase activity was detected in
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the soluble phase. In contrast to the notable dependence of the 
mitochondrial enzyme activities upon exogenous NAD+ and CoA, the 
soluble activities exhibited some requirement for NAD+, but no 
observable, need for added CoA. These results merit discussion in 
view of the observed absence of branched-chain keto acid dehydro­
genase activity in branched-chain a-keto aciduria (BCKA). If two 
types of branched-chain keto acid dehydrogenase exist, one 
localized in the mitochondria and another in the soluble phase of 
the cell they are evidently closely’ related at the genetic level.
Loss of these enzymatic capabilities, through an inherited genetic 
lesion, would then result in total inability (in classic branched- 
chain ketoaciduria) to catabolize these keto acids.
It is generally accepted that the oxidative decarboxylation of 
pyruvate and a-ketoglutarate, in mammalian tissues, is catalyzed by 
separate dehydrogenases complexes (38), each possessing a relatively 
high degree of substrate specificity. O-Ketoglutarate dehydrogenase 
in nearly completely specific for a-keteglutarate with a minor ability 
to decarboxylate a-ketoadipate. On the other hand, the pyruvate 
dehydrogenase of pig heart mitochondria is capable of oxidizing 
either pyruvate or a-ketobutyrate at substantial rates (38). Studies 
reported here, i.e. differential response of these activities to 
mild heating, and nearly additive reaction rates in the mixed 
substrate experiments (Table 7) support the conclusion of separate 
a-ketoglutarate and pyruvate dehydrogenase complexes in bovine liver 
mitochondria.
Close scrutiny of the data shown in Appendix II will reveal that 
protein intake (discussed above) results in accumulation of KIC, KMV
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and KIV in concentrations which approach, and in some instances exceed 
the calculated inhibition constants for these keto acids (see Table 9) 
For example the concentration of KIC may reach 0.5 mM, which is 
significantly greater than its inhibition constant against KIV 
dehydrogenase activity. These mutual inhibitory interactions among 
the branched-cfciain a~keto acids would thus enable the organism to 
maintain cellular homeostasis by permitting the preferential oxidation 
of a particular keto acid present in excess amounts. This phenomenon 
could attain a significant physiological role in the event of a 
disparity in the concentration of these metabolites in the tissues.
In dietary intake of protein from certain sources, for example, 
large amounts of milk protein, which has a high leucine content (32), 
the situation described above would be expected to occur quite 
commonly.
Possibly the most important consequence of elevated branched-
chaln amino acid and a-keto acid concentrations in the cells is the
potential modulating effect of these acids upon the utilization of
carbohydrate. As can be seen in Table 9, each of the branched-chain
Oi-keto acids is able to inhibit the oxidatior of pyruvate and 0L-
ketoglutarate. The apparent inhibition constant (K^) for KIC
against the effective pyruvate dehydrogenase activity was determined
to be approximately 0.5 mM. When the level of KIC in plasma and
liver increases subsequent to high dietary consumption of protein,
this K. is sufficiently low so as to allow a marked reduction in the r
rate of oxidation of pyruvate to acetyl CoA.
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Kinetic constants, K , were determined conventionally by 
application of the relationship shown in equation 12. Furthermore, 
since the inhibition of pyruvate oxidation by KIC is of the 
competitive type, equation 13 was applicable for the calculation 
of the inhibitor constants, K.. Use of these constants then 
allowed for calculation of the per cent inhibition of the 
dehydrogenase activity with equation lh, as proposed by Nordlie 
(87), at any suitable levels of substrate and inhibitor (v. as 
used in equations 13 and 14 refers to the initial reaction 
velocity in the presence of inhibitor).
V /pyruvate/ max —  ̂ —
+ /pyruvate^/
(12)
V /pyruvate/ max —
iKIC/1 + ---------- | kK. | m /pyruvate/
(v - v .) x 100 Per cent inhibition = ______1_______
(13/
Pyruvate concentrations in rat liver are reported to range from 
0.034 mM for 2k hour fasted animals to approximately 0.2 mM in 
the fed rat (88). Assuming that these results can be extrapolated 
to other mammals, the following situations would obtain. In 
mammalian liver, KIC concentrations of about 0.1 mM (lower end of 
the normal range, see Appendix II) would decrease the pyruvate 
dehydrogenase activity only slightly (five to ten per cent) in the 
fed animal. However, if the level of KIC reaches a somewhat 
elevated concentration, such as is known to occur after consumption
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of increased amounts of protein, inhibition is considerably greater 
(about 35 per cent). Under these conditions, this represents nearly 
a four-fold potentiation in the inhibition of pyruvate oxidation.
By comparison, KMV concentrations in the normal range of 0.08 mM to 
0.2 mM (see Appendix II) would result in merely a two to five per 
cent inhibition of pyruvate dehydrogenase activity in the fed animal.
In contrast, the oxidation of a-ketoglutarate is less likely to 
be influenced by these conditions, since the reported levels of plasma 
and liver branched-chain a-keto acids remain somewhat below the 
apparent K_ values for KIC, KMV and KIV against the a-ketoglutarate 
dehydrogenase activity. By way of illustration, continued 
administration of a 25 per cent casein hydrolysate to diet-stabilized 
rats caused the concentration of a-ketoisocaproate to rise 
significantly, to a value of approximately 0.^ mM. This concentration 
is considerably lower than the estimated (2.^ mM) for KIC.
A second, indirect effect of elevated KIC, KMV and KIV lies in 
the fact that the catabolism of these compounds leads ultimately to 
succinyl-CoA and acetyl-CoA., each of which has been reported to 
inhibit the enzymatic functions of a-ketoglutarate dehydrogenase and 
pyruvate dehydrogenase (8 9 ) .  The combined effects of these direct 
and indirect inhibitions by branched-chain a-keto acids on the 
metabolism of pyruvate and a-ketoglutarate could thus constitute a 
significant physiological regulatory phenomenon. In this way, the 
branched-chain a-keto acids may be able to promote their own 
catabolism, since oxidation of excess branched-chain compounds would 
be favored, until normal cellular concentrations are reattained,
at which time the inhibitory effects would become slight.
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Other potential points of inter-regulation of branched-chain
a-keto acid catabolism are suggested by the effects of added Mg+^
and ATP. Linn, Pettit and Reed (90) have recently reported that
mammalian pyruvate dehydrogenase is inactivated by ATP in the
presence of a specific kinase enzyme. A phosphatase, in the presence
of Mg'^, reactivates the pyruvate dehydrogenase complex. While
speculation that a similar sequence of events may function to
regulate the catabolism of the branched-chain a-keto acids is
intriguing, the ultimate proof of such a mechanism will depend
upon eventual isolation of the dehydrogenase complex. The dramatic
stimulation of branched-chain a-keto acid dehydrogenase activity
+2of whole mitochondria by Ca and inorganic phosphate is not+2understood. A similar effect of Ca on this activity was noted
by Wohlheuter and Harper (ll) in rat liver mitochondria. They also
utilized rather high concentrations of phosphate buffer (150 mM),
but apparently did not investigate the effects of this agent on
the branched-chain a-keto acid dehydrogenase activities. Inorganic
phosphate (9 1) and Ca^ (92) are known to be potent mitochondrial
swelling agents at the concentrations utilized in the assay medium
upon which these studies are largely based. The possibility that
changes in the structural state of mitochondria give rise to the
observed enzymatic changes can not be disregarded. The relative
+2 +2intramitochondrial concentrations of Mg , Ca , ATP and P^ may 
provide a finely intermeshed regulatory system to supplement 
the major regulatory aspects mentioned earlier in this discussion.
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Interposition of a physical barrier such as a biological membrane 
between a metabolite and an enzyme functioning in the conversion of 
that metabolite may introduce an additional regulatory aspect.
The selective permeability of the inner membrane of mammalian 
mitochondria could constitute such a barrier. If the metabolite 
is formed outside of this membrane, and is to be catabolized inside 
of the membrane, that substrate must either diffuse through or be 
transported across the membrane barrier. The enzyme localization 
studies presented here, which indicate that the branched-chain a- 
keto acid dehydrogenase oxidation site is on the outer face of the 
inner membrane, would apparently abolish the consideration of 
permeation of substrate or translocase action as a factor 
controlling the oxidation of the branched-chain ct-keto acids. In 
contrast, the mixed type of inhibition of a-ketoglutarate 
dehydrogenase activity, which was noted above, could in theory 
reflect dual inhibitory effects of the branched-chain a-keto acids 
at the a-ketoglutarate translocase (53) site, and at a catalytic 
site on the enzyme within the mitochondrial inner membrane.
Although the localization studies predict that pyruvate dehydrogenase 
faces the matrix side of the inner membrane, earlier stuoies have 
demonstrated that pyruvate can transverse the inner membrane with 
little difficulty (93)•
Among the outstanding biochemical characteristics of the 
disease branched-chain ketoaciduria are (a) abnormal accumulation 
of leucine, isoleucine and valine in the brain, liver, plasma and 
spinal fluid; (b) a corresponding increase in the branched-chain
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a-keto acid ( K I C ,  KMV, K I V )  concentrations in these same tissues;
and (c) extraordinarily large amounts of these amino and a-keto acids
in the urine of the diseased patients (17). The distinctive maple
syrup odor of the urine and other bodily secretions has been
attributed to the accumulation of a polymeric form of a-hydroxy-
butyrate derived from a-ketobutyrate (9̂ +.>95)> or to the presence
of a-keto-p-methylvaleric acid (KMV) (19). Menkes (17) reported
that the excretion of pyruvate and a-ketoglutarate in the urine
of persons with branched-chain ketoaciduria was normal. In a more
recent communication, however, Woody (96) indicates that a-keto-
glutarate levels of the urine increase significantly in those
patients showing advanced neurological symptoms of the disease.
Increased excretion of this compound could be a consequence of th-
effective inhibition of a-ketoglutarate oxidation by the branched-
chain a-keto acids or alternatively by an inhibitory effect of
these keto acids on reabsorption of KG in the renal tubules, as
was suggested by Lysiak et_ al. (97)«
Inhibition of the activity of pyruvate dehydrogenase by KIC has
been investigated semi-quantitatively in rat liver (37^39) and
brain (37)* Kanzaki e_t al. (38) have shown that KMV and KIV
inhibit the activity of the purified pyruvate dehydrogenase from pig
heart. They did not establish the inhibitory capacity of KIC upon
pyruvate dehydrogenase activity because they considered this keto
acid as a substrate. Their results, which describe an apparent
_2Michaelis constant value of 1+.3 x 10 M for KIC, indicate that this 
branched-chain a-keto acid is an extremely poor substrate for the
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pyruvate dehydrogenase complex, formal levels of KIC in the liver
cell are two to three orders of magnitude below the K that theym
have specified. In general, the results obtained here dealing 
with the effects of the branched-chain a-keto acids on bovine 
liver pyruvate dehydrogenase correspond closely to those determined 
for the purified complex. As was noted earlier, the branched-chain 
a-keto acids are also capable of inhibiting the oxidative decarboxyl­
ation of a-ketoglutarate. Based upon the apparent inhibition 
constants (Table 9), each of which was found to be near 10 and 
the reported concentrations reported for the branched-chain a-keto 
acids in the branched-chain ketoaciduria individuals (see Appendix 
II), a significant depression of a-ketoglutarate dehydrogenase 
activity would be likely to result. That the inhibitory effects 
on a-ketoglutarate dehydrogenase are evident only when tissue 
levels of KIC, KMV and KIV are highest is consistent with the 
previous observation that a-ketoglutarate accumulates in the plasma 
and is excreted in abnormal amounts by the kidney during the semi- 
comatase, ataxic state of the terminal stages of the disease.
Although the exact cause of the neurological pathology commonly 
associated with branched-chain ketoaciduria is not known, a 
correlation between the neurologic symptoms and elevated leucine 
and KIC has been established (19). The results of the mutual 
inhibition studies which were summarized in Table 9 disclose that 
KIC is the most potent inhibitor of pyruvate oxidation among tne 
three branched-chain keto acids. Concentrations of KIC have been 
reported to exceed 2.5 tilt in plasma, and 0.8 mM in brain tissue of
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BCKA patients (18,19*37)• It Is evident that the metabolism of 
pyruvate dehydrogenase would be severely impaired by these 
concentrations of KIC, which range from two to five times the 
calculated value for the K. (0.5^ mM) of this branched-chain keto 
acid. The effects of KMV and KIV on the oxidative decarboxylation 
of pyruvate would be minimal by comparison to those of KIC, in view 
of their considerably higher inhibition constants on pyruvate 
dehydrogenase.
The observed accumulation of a-ketobutyrate in tissues of 
persons afflicted with branched-chain ketoaciduria may also result 
from inhibition of the pyruvate dehydrogenase complex, if in fact 
this enzyme is the primary decarboxylase of a-ketobutyrate.
The decreased production of acetyl CoA from pyruvate, which 
is a natural result of the obstruction of pyruvate dehydrogenase 
activity, has at least two major consequences. The first, and 
probably the more important of these effects, is the limitation 
placed upon the amount of acetyl-CoA entering the tricarboxylic 
acid cyle from carbohydrate metabolism. This phenomenon, coupled 
with the simultaneous inhibition of a-ketoglutarate dehydrogenase 
activity, would greatly diminish the total energy production by 
the affected tissues. Secondly, reduced availability of acetyl-CoA 
would have a depressing effect upon lipid synthesis, necessary for 
the deposition of myelin in the developing brain. Decreased 
myelination in certain primitive areas of the brain has been proposed 
as a contributory factor to the mental deficiencies of untreated 
branched-chain ketoaciduria (9̂ -) • Elevated levels of KIC are also
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theorized to affect the synthesis of the cerebronic acids which 
are essential for myelin formation (3^)* It should be noted that 
clinical studies indicate that the lack of myelination which does 
occur is probably not in itself sufficient to account for the 
acute neurological syndrome (19 .,3̂-)*
Finally, two other effects of elevated branched-chain a-keto
and amino acids have been noted. Concentrations of these amino
- -3acids in the range of 10 M are known to inhibit the activity of 
ornithine-keto acid transaminase (OKT), an enzyme which has a role 
in regulating the activity of the Krebs urea cycle (98). Impaired 
function of this pathway would be expected to have an undesirable 
influence upon the nitrogen metabolism of the organism. Excessive 
leucine (2 rriM) and alloisoleucine are known to induce hypoglycemia 
and to inhibit glueoneogen.esis from lactate (llO,̂ l,42) . The site 
of this inhibition has not been elucidated.
In general, then, a variety of potentially deleterious 
consequences of the reduced ability of the organism to metabolize 
a-ketoglutarate and pyruvate may be expected to underlie the 
symptoms and pathology of branched-chain ketoaciduria. The 
catabolism of carbohydrate by the Krebs tricarboxylic acid cycle, 
to which pyruvate dehydrogenase is an important point of entry 
and of which a-ketoglutarate dehydrogenase is a part, is responsible 
for production of a significant portion of the reduced pyridine 
nucleotide (NADH) necessary for the subsequent formation of high 
energy phosphate bonds. Interference with these processes through 
the effective inhibition of pyruvate and a-ketoglutarate oxidation
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would seriously affect the ability of the organism to maintain 
the desired cellular homeostasis, and would decrease the anabolic 
capacity of the affected tissues.
Thus, in the normal, and certainly more so in the abnormal 
(excess branched-chain amino and a-keto acids) mammal, fluctuations 
in the levels of branched-chain a-keto acids could contribute 
significantly to the regulation of the levels of these metabolites, 
to the status of the rates of pyruvate and a-ketoglutarate 
metabolism, and to the resulting metabolic consequences.
APPENDICES
APPENDIX I




A. Prepar- cion of 2 % (w/v) Digitonin Solution.
Add fivi ml of warm 0.25 M sucrose to 0.1 g of powdered 
digitoni . Mix briefly. Sonicate for one to two minutes 
in an ult -asonic bath. The resulting clear solution 
remains cl 2ar foi. 3*D to 60 min at 30°C.
3. Triton-Uree Reagent (if%).
Saturate 50 1 ml of distilled-deionized water with solid 
urea at room temperature. Add if °j0 (by volume) Triton X-100 
detergent.
C. Biuret Reagent.
Dissolve 6.0 1 of sodium-potassium tar”rate in 500 ml of water. 
Add 1.5 g of ::uS0^*5H20. Combine with 300 ml of 10 % sodium 
hydroxide sol '.tion. Dilute to one liter with water.
D. Folin-Ciocalt.au Reagents (for Lowry protein determinations).
Reagent A: ombined 20 g of Na^CO^, if g of solid NaOH. and
!00 mg cf sodium potassium tartrate. Dilute to 
one liter with distilled-deionized water.
Reagent B: Combine five grams of CuSO^^H^O with one liter
of water.
Reagent Cr Combine 50 parts Reagent A with one part 
Reagent B. Prepare fresh daily.
APPENDIX II
Concentration ranges for some amino acids and a-keto acids 




SOME AMINO ACID AND a-KETO ACID CONCENTRATIONS 
CHAIN KETOACIDURIC TISS


















mM mM mM mM
Leucine o . i  -  0 .5 - a-ketoiso-
caproate
o . i  -  0 .5 rat liver (8 6 ) (9 9 )
Leucine 0 .1  - 0 .4 4 -6 a-ketoiso-
caproate
o . i  -  0 .4 2 -4 human plasma (19 )
Leucine 0 .0 1 0 .4 3 a-Ketoiso-
caproate
0 .0 1 0 .4 3 human spinal 
fluid
(19)
Isoleucine 0 .0 8 -0 .2 - a-keto-(3-
methylvalerate
0 .0 8 -0 .2 - rat liver (99 )
Iscleucine 0 .0 7 -0 .2 5 l . o - l . 5 a-keto-p-
methylvalerate
0 . 07 - 0 .2 5 1 .0 -1 .5 human plasma (19 )
Isoleucine o .o o 4 0 .2 2 a-keto-p-
methvlvalerate
o .o o 4 0 .2 2 human spinal 
fluid
(19 )




TABLE 10 —  Continued
Ami no Normal BCKAa Ct-Keto Approximate Approximate
Ac id Concentration Concentration Acid Normal BCKA Tissues References
Range Range Range Range
Valine 0.2U 1.8 5 dt-ketoiso- 0 .2 5 1 .8 5 human plasma (19)
valerate
Valine 0 . 011+ 0 .3 2 a-ketoiso- 0.011+ 0 .3 2 human spinal (19)
valerate fluid
pyruvate 0 .2 - rat liver 
(fed)
(88)
pyruvate 0 .0 3 - rat liver(2l+ hr. fast) (88)
BCKA is the abbreviation for branched-chain ketoaciduria.
^Based on a K of approximately one for the transamination reaction (ll+).
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